https://curecurrent.com/trials/metformin-add-on-clinical-study-in-multiple-sclerosis-to-evaluate-brain-remyelination-and-neurodegeneration-105006https://curecurrent.com/trials/a-specialized-diet-for-multiple-sclerosis-105007https://curecurrent.com/trials/the-effect-of-a-series-of-systemic-cryotherapy-treatments-on-the-functional-state-of-patients-with-multiple-sclerosis-105008https://curecurrent.com/trials/prospective-effectiveness-and-safety-study-of-cladribine-in-participants-who-change-first-line-dmd-treatments-for-multip-105009https://curecurrent.com/trials/protective-stepping-in-people-with-ms-105010https://curecurrent.com/trials/a-teleheath-tdcs-approach-to-decrease-cannabis-use-105011https://curecurrent.com/trials/measurement-of-relaxin-peptide-in-multiple-sclerosis-ms-105012https://curecurrent.com/trials/long-term-extension-to-study-ac-058b301-to-investigate-safety-tolerability-and-disease-control-of-ponesimod-20-mg-in-pat-105013https://curecurrent.com/trials/screening-for-cognitive-disorders-in-multiple-sclerosis-105014https://curecurrent.com/trials/remote-ms-care-in-antwerp-105015https://curecurrent.com/trials/exopulse-mollii-suit-motor-function-multiple-sclerosis-105016https://curecurrent.com/trials/prospective-randomized-endovascular-therapy-in-multiple-sclerosis-premise-105017https://curecurrent.com/trials/effectiveness-of-the-exopulse-mollii-suit-in-patients-with-multiple-sclerosis-105018https://curecurrent.com/trials/feasibility-of-a-vocational-rehabilitation-intervention-for-job-retention-in-workers-with-ms-rialsm-intervention-project-105019https://curecurrent.com/trials/fatigue-in-multiple-sclerosis-and-its-relationship-to-inflammatory-and-neurodegenerative-markers-of-the-disease-105020https://curecurrent.com/trials/reliability-and-validity-of-the-turkish-version-of-general-sleep-disturbance-scale-gsds-t-in-multiple-sclerosis-105021https://curecurrent.com/trials/multimodal-exercise-training-to-reduce-frailty-in-people-with-multiple-sclerosis-105022https://curecurrent.com/trials/covid-19-knowledge-attitudes-practices-and-perceived-risk-cross-sectional-mixed-methods-105023https://curecurrent.com/trials/ms-detect-early-detection-of-multiple-sclerosis-progression-with-mscopilot-detect-105024https://curecurrent.com/trials/study-of-evobrutinib-in-participants-with-rms-evolutionrms-1-105025https://curecurrent.com/trials/study-describing-cognitive-processing-speed-changes-in-relapsing-multiple-sclerosis-subjects-treated-with-ozanimod-rpc-1-105026https://curecurrent.com/trials/intrathecal-administration-of-autologous-mesenchymal-stem-cell-derived-neural-progenitors-msc-np-in-progressive-multiple-105027https://curecurrent.com/trials/dry-needling-in-multiple-sclerosis-105028https://curecurrent.com/trials/respiratory-muscle-training-program-in-patients-with-multiple-sclerosis-105029https://curecurrent.com/trials/the-effect-of-physical-activity-levels-on-dysmenorrhea-severity-menstrual-symptoms-and-functional-and-emotional-status-i-105030https://curecurrent.com/trials/ketamine-for-ms-fatigue-105031https://curecurrent.com/trials/bazedoxifene-acetate-as-a-remyelinating-agent-in-multiple-sclerosis-105032https://curecurrent.com/trials/nasal-foralumab-in-patients-with-non-active-secondary-progressive-multiple-sclerosis-105033https://curecurrent.com/trials/intermediate-size-patient-population-expanded-access-foralumab-in-non-active-secondary-progressive-ms-patients-105034https://curecurrent.com/trials/exercise-training-effects-on-cognition-and-brain-function-in-multiple-sclerosis-project-exact-105035https://curecurrent.com/trials/a-pilot-study-to-explore-the-role-of-gut-flora-in-multiple-sclerosis-105036https://curecurrent.com/trials/effect-of-bobath-therapy-on-balance-alterations-in-patients-with-multiple-sclerosis-105037https://curecurrent.com/trials/basimglurant-noe-101-in-children-adolescents-and-young-adults-with-tsc-105038https://curecurrent.com/trials/the-effect-of-task-oriented-training-and-virtual-reality-training-on-balance-gait-and-fatigue-in-individuals-with-multip-105039https://curecurrent.com/trials/educational-kinesiology-program-s-effect-on-cognition-manual-dexterity-and-bimanual-coordination-in-ms-patients-105040https://curecurrent.com/trials/cerebellar-high-frequency-rtms-in-balance-of-multiple-sclerosis-patients-105041https://curecurrent.com/trials/assessment-of-ank-700-in-patients-with-relapsing-remitting-multiple-sclerosis-105042https://curecurrent.com/trials/autologous-hematopoietic-stem-cell-transplantation-for-refractory-multiple-sclerosis-105043https://curecurrent.com/trials/effects-of-blood-flow-restriction-training-on-middle-aged-people-with-multiple-sclerosis-105044https://curecurrent.com/trials/demyelination-and-remyelination-in-multiple-sclerosis-ms-detected-by-brain-amyloid-pet-ct-105045https://curecurrent.com/trials/feasibility-study-of-a-relapse-investigation-questionnaire-administered-by-an-ms-care-coordinator-nurse-in-patients-with-105046https://curecurrent.com/trials/tdcs-combined-with-treadmill-training-in-patients-with-multiple-sclerosis-105047https://curecurrent.com/trials/validity-and-reliability-of-the-12-item-multiple-sclerosis-walking-scale-12-ws-in-subjects-with-spinal-cord-injury-105048https://curecurrent.com/trials/transcranial-electrical-stimulation-in-multiple-sclerosis-105049https://curecurrent.com/trials/structured-exercise-training-in-newly-diagnosed-multiple-sclerosis-105050https://curecurrent.com/trials/effect-of-a-mobile-health-app-on-pain-and-quality-of-life-in-patients-with-neuropathic-pain-in-multiple-sclerosis-105051https://curecurrent.com/trials/retinal-neuro-vascular-coupling-in-patients-with-multiple-sclerosis-105052https://curecurrent.com/trials/interest-of-a-musical-intervention-on-stress-induced-during-botulinum-toxin-injections-in-spasticity-musibot-105053https://curecurrent.com/trials/retinal-markers-in-neuroinflammatory-diseases-remind-105054https://curecurrent.com/trials/the-effect-of-virtual-reality-on-fatigue-and-functional-capacity-in-patients-with-ms-105055https://curecurrent.com/trials/an-extension-clinical-study-of-the-efficacy-and-safety-of-bcd-132-in-patients-with-multiple-sclerosis-who-previously-rec-105056https://curecurrent.com/trials/fit-atomic-exercise-feasibility-trial-105057https://curecurrent.com/trials/trunk-restraint-in-multiple-sclerosis-105058https://curecurrent.com/trials/online-program-to-reduce-depression-in-ms-105059https://curecurrent.com/trials/effects-of-torso-weighting-on-muscle-activation-during-balance-tests-in-individuals-with-and-without-multiple-sclerosis-105060https://curecurrent.com/trials/early-identification-of-brain-lesions-in-multiple-sclerosis-with-phase-sensitive-inversion-recovery-mri-105061https://curecurrent.com/trials/qualitative-study-in-patients-with-genodermatoses-and-healthcare-professionals-on-reproductive-counselling-105062https://curecurrent.com/trials/reproductive-options-in-inherited-skin-diseases-105063https://curecurrent.com/trials/visual-processing-speed-and-objective-analysis-of-ocular-movements-in-multiple-sclerosis-105064https://curecurrent.com/trials/exploring-the-immune-response-to-sars-cov-2-covid-19-vaccines-in-patients-with-relapsing-multiple-sclerosis-rms-treated-105065https://curecurrent.com/trials/territorial-implementation-and-evaluation-of-a-multiple-sclerosis-expert-patient-program-105066https://curecurrent.com/trials/a-open-label-study-to-assess-response-to-covid-19-vaccine-in-multiple-sclerosis-participants-treated-with-ofatumumab-105067https://curecurrent.com/trials/a-study-of-dimethyl-fumarate-dmf-in-relapsing-forms-of-multiple-sclerosis-rms-participants-in-china-105068https://curecurrent.com/trials/evaluation-of-the-microbiome-in-multiple-sclerosis-105069https://curecurrent.com/trials/swiss-multiple-sclerosis-registry-105070https://curecurrent.com/trials/a-study-of-efficacy-and-safety-of-m2951-in-participants-with-relapsing-multiple-sclerosis-105071https://curecurrent.com/trials/exercise-therapy-in-multiple-sclerosis-105072https://curecurrent.com/trials/effectiveness-of-personalized-alternating-current-stimulation-for-treating-cognitive-impairment-in-cns-demyelination-pat-105073https://curecurrent.com/trials/study-to-assess-the-efficacy-of-mayzent-on-microglia-in-secondary-progressive-multiple-sclerosis-105074https://curecurrent.com/trials/topik-study-a-study-to-report-progressive-multifocal-leukoencephalopathy-and-other-serious-opportunistic-infections-in-n-105075https://curecurrent.com/trials/covid-19-vaccine-biomarker-study-in-multiple-sclerosis-105076https://curecurrent.com/trials/multiscript-cycle-1-personalized-medicine-in-multiple-sclerosis-pragmatic-platform-trial-embedded-within-the-smsc-105077https://curecurrent.com/trials/optimising-access-to-vocational-rehabilitation-for-people-with-multiple-sclerosis-105078https://curecurrent.com/trials/examining-the-effect-of-mandala-art-therapy-on-symptoms-and-quality-of-life-in-multiple-sclerosis-patients-105079https://curecurrent.com/trials/cognitive-rehabilitation-of-deficits-in-patients-with-multiple-sclerosis-105080https://curecurrent.com/trials/epstein-barr-virus-infection-in-patients-with-radiologically-isolated-syndrome-105081https://curecurrent.com/trials/study-of-ng01-cell-therapy-in-secondary-progressive-multiple-sclerosis-105082https://curecurrent.com/trials/the-effect-of-inspiratory-muscle-training-on-balance-and-postural-control-in-multiple-sclerosis-patients-105083https://curecurrent.com/trials/illuminating-new-paths-in-the-treatment-of-multiple-sclerosis-relapses-early-and-specialized-rehabilitation-105084https://curecurrent.com/trials/expression-of-parp-1-in-multiple-sclerosis-patients-105085https://curecurrent.com/trials/multiple-sclerosis-and-overactive-bladder-treatment-105086https://curecurrent.com/trials/administration-of-fingolimod-in-greek-patients-with-multiple-sclerosis-105087https://curecurrent.com/trials/tj-68-clinical-trial-in-patients-with-amyotrophic-lateral-sclerosis-als-and-muscle-cramps-105088https://curecurrent.com/trials/idp-023-g-nk-cells-plus-ocrelizumab-in-patients-with-progressive-multiple-sclerosis-105089https://curecurrent.com/trials/laughter-yoga-for-improving-sexual-function-and-psychosocial-outcomes-in-multiple-sclerosis-105090https://curecurrent.com/trials/upper-limb-function-in-mental-health-disorders-105091https://curecurrent.com/trials/a-study-of-suboptimally-controlled-participants-previously-taking-injectable-dmds-for-rms-click-ms-105092https://curecurrent.com/trials/effect-of-dual-task-training-and-cognitive-rehabilitation-in-individuals-with-multiple-sclerosis-105093https://curecurrent.com/trials/optimizing-detection-and-prediction-of-changes-in-cognitive-function-in-multiple-sclerosis-ms-105094https://curecurrent.com/trials/epidural-stimulation-in-multiple-sclerosis-105095https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-kinetics-biodistribution-and-repeatability-of-11c-bms-986196-after-intraveno-105096https://curecurrent.com/trials/a-study-to-assess-the-potential-impact-of-disease-modifying-therapies-on-covid-19-outcomes-and-the-antibody-response-fol-105097https://curecurrent.com/trials/smart-monitoring-assessing-spasticity-related-health-105098https://curecurrent.com/trials/comparison-between-all-immunotherapies-for-multiple-sclerosis-105099https://curecurrent.com/trials/reliability-of-kinovea-in-gait-assessment-in-multiple-sclerosis-a-pilot-study-105100https://curecurrent.com/trials/proximal-resistance-training-for-people-with-multiple-sclerosis-105101https://curecurrent.com/trials/pelvic-proprioceptive-neuromuscular-facilitation-pnf-exercises-in-multiple-sclerosis-patients-105102https://curecurrent.com/trials/prospective-stratification-of-infectious-risks-in-multiple-sclerosis-105103https://curecurrent.com/trials/exploring-pathology-related-to-slowly-expanding-lesions-using-advanced-imaging-105104https://curecurrent.com/trials/portable-neuromodulation-stimulator-registry-for-people-with-multiple-sclerosis-105105https://curecurrent.com/trials/a-study-to-assess-the-effectiveness-and-safety-of-ozanimod-in-chinese-adults-with-relapsing-multiple-sclerosis-105106https://curecurrent.com/trials/swiss-multiple-sclerosis-cohort-study-105107https://curecurrent.com/trials/effect-of-teriflunomide-treatment-on-microglial-activation-in-an-ms-patient-cohort-at-risk-of-progression-105108https://curecurrent.com/trials/impact-of-the-modifications-of-environmental-exposures-and-health-care-access-during-covid-19-lockdown-on-multiple-scler-105109https://curecurrent.com/trials/tens-in-persons-with-ms-105110https://curecurrent.com/trials/effects-of-sailing-and-cooing-in-the-quality-of-life-of-multiple-sclerosis-individuals-105111https://curecurrent.com/trials/safety-of-cultured-allogeneic-adult-umbilical-cord-derived-mesenchymal-stem-cell-intravenous-infusion-for-ms-105112https://curecurrent.com/trials/quantified-balance-measures-during-stance-and-gait-multiple-sclerosis-patients-a-longitudinal-clinical-study-105113https://curecurrent.com/trials/don-t-be-late-postponing-cognitive-decline-and-preventing-early-unemployment-in-people-with-multiple-sclerosis-105114https://curecurrent.com/trials/improving-the-treatment-of-acute-relapses-in-multiple-sclerosis-through-intranasal-methylprednisolone-administration-105115https://curecurrent.com/trials/melatonin-in-patients-with-multiple-sclerosis-ms-105116https://curecurrent.com/trials/clinical-study-to-investigate-the-long-term-safety-tolerability-and-efficacy-of-ponesimod-in-patients-with-relapsing-rem-105117https://curecurrent.com/trials/clinical-study-to-evaluate-the-efficacy-safety-and-tolerability-of-act-128800-in-patients-with-relapsing-remitting-multi-105118https://curecurrent.com/trials/the-ms-ceba-study-determining-cognitive-energetic-behavioural-and-affective-ceba-profiles-in-multiple-sclerosis-105119https://curecurrent.com/trials/oral-ponesimod-versus-teriflunomide-in-relapsing-multiple-sclerosis-105120https://curecurrent.com/trials/probiotic-chocolate-study-in-multiple-sclerosis-105121https://curecurrent.com/trials/adapting-mhealth-technology-to-improve-patient-activation-105122https://curecurrent.com/trials/a-therapeutic-experience-program-tep-study-for-improvement-of-gait-in-people-with-multiple-sclerosis-ms-105123https://curecurrent.com/trials/a-wheelchair-propulsion-training-program-105124https://curecurrent.com/trials/a-study-of-allogeneic-hematopoietic-cell-transplantation-for-primary-progressive-multiple-sclerosis-105125https://curecurrent.com/trials/metabolic-imaging-of-neurological-disease-105126https://curecurrent.com/trials/a-study-of-multiple-sclerosis-routine-clinical-practice-impact-on-adherence-and-clinical-outcomes-of-ofatumumab-treated-105127https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-pd-of-gsk3888130b-in-healthy-participants-105128https://curecurrent.com/trials/effectiveness-of-ofatumumab-in-real-world-practice-105129https://curecurrent.com/trials/a-canadian-study-of-persistence-on-ofatumumab-using-patient-support-program-data-105130https://curecurrent.com/trials/rehabilitative-protocols-in-progressive-multiple-sclerosis-treated-with-anti-cd20-monoclonal-antibodies-105131https://curecurrent.com/trials/study-of-evobrutinib-in-participants-with-rms-evolutionrms-2-105132https://curecurrent.com/trials/acupressure-in-ms-patients-105133https://curecurrent.com/trials/effects-of-ms-ballroom-fitness-on-balance-walking-capacity-and-well-being-in-multiple-sclerosis-105134https://curecurrent.com/trials/the-effect-of-online-pilates-on-cognitive-function-and-dual-task-performance-105135https://curecurrent.com/trials/investigation-of-validity-and-reliability-of-the-minnesota-manual-dexterity-test-in-patients-with-multiple-sclerosis-105136https://curecurrent.com/trials/nerve-root-block-in-spasticity-105137https://curecurrent.com/trials/ukulele-playing-to-improve-cognition-in-people-with-multiple-sclerosis-a-feasibility-study-105138https://curecurrent.com/trials/intravoxel-incoherent-motion-ivim-magnetic-resonance-imaging-in-multiple-sclerosis-105139https://curecurrent.com/trials/evaluation-of-the-efficacy-of-transcranial-direct-current-stimulation-in-reducing-fatigue-and-improving-quality-of-life-105140https://curecurrent.com/trials/short-arm-human-centrifuge-therapeutic-training-and-rehabilitation-gracer1-105141https://curecurrent.com/trials/validity-and-reliability-of-the-modified-four-square-step-test-in-multiple-sclerosis-patients-105142https://curecurrent.com/trials/effectiveness-of-exergaming-in-adittion-to-conventional-treatment-for-physical-therapy-in-people-with-multiple-sclerosis-105143https://curecurrent.com/trials/frequency-of-fcgr3a-gene-polymorphisms-in-patients-with-neuromyelitis-optica-spectrum-disorders-anti-oligodendrocyte-mye-105144https://curecurrent.com/trials/virtual-reality-in-physical-therapy-in-multiple-sclerosis-105145https://curecurrent.com/trials/the-therapeutic-effects-of-forced-aerobic-exercise-in-multiple-sclerosis-105146https://curecurrent.com/trials/pilates-versus-eccentric-exercises-on-multiple-sclerosis-105147https://curecurrent.com/trials/observational-study-of-persistence-on-bafiertam-treatment-in-routine-clinical-practice-105148https://curecurrent.com/trials/pet-with-18f-flumazenil-as-an-index-of-neurodegeneration-in-ms-105149https://curecurrent.com/trials/lipoic-acid-for-progressive-multiple-sclerosis-ms-105150https://curecurrent.com/trials/dubousset-functional-test-an-investigation-of-its-validity-and-reliability-in-individuals-with-multiple-sclerosis-105151https://curecurrent.com/trials/effect-of-variance-on-error-correction-during-coupling-105152https://curecurrent.com/trials/exercise-training-cognition-and-mobility-in-older-adults-with-multiple-sclerosis-105153https://curecurrent.com/trials/auditory-motor-coupling-in-multiple-sclerosis-with-cerebellar-lesions-105154https://curecurrent.com/trials/rel-ab-l-ty-and-val-d-ty-of-the-two-minute-test-w-th-multiple-sclerosis-105155https://curecurrent.com/trials/adverse-childhood-experiences-in-patients-with-ms-impact-on-quality-of-life-and-on-coping-strategies-towards-the-disease-105156https://curecurrent.com/trials/aerobic-exercise-for-urinary-incontinence-in-multiple-sclerosis-105157https://curecurrent.com/trials/combined-effects-of-balance-and-cognitive-training-in-patients-with-multiple-sclerosis-105158https://curecurrent.com/trials/the-effect-of-a-mediterranean-diet-on-quality-of-life-in-multiple-sclerosis-patients-105159https://curecurrent.com/trials/redcord-in-neurogenic-bowel-dysfunction-in-multiple-sclerosis-105160https://curecurrent.com/trials/impact-of-virtual-reality-physiotherapy-on-multiple-sclerosis-patients-105161https://curecurrent.com/trials/mechanism-of-action-of-ocrelizumab-in-multiple-sclerosis-105162https://curecurrent.com/trials/effect-of-motor-cognitive-interference-on-cognition-and-quality-of-life-on-patients-with-multiple-sclerosis-105163https://curecurrent.com/trials/comparative-study-of-the-efficacy-and-safety-of-bcd-132-with-teriflunomide-and-placebo-in-multiple-sclerosis-105164https://curecurrent.com/trials/testing-the-feasibility-of-computer-based-cognitive-training-in-individuals-with-multiple-sclerosis-living-in-the-commun-105165https://curecurrent.com/trials/effect-of-high-tone-power-therapy-on-bladder-disturbance-105166https://curecurrent.com/trials/trial-to-assess-the-safety-and-feasibility-of-adoptive-cell-therapy-with-autologous-ebv-specific-cytotoxic-t-lymphocytes-105167https://curecurrent.com/trials/cerebellar-rtms-in-patients-with-multiple-sclerosis-105168https://curecurrent.com/trials/iconquerms-a-patient-powered-research-network-for-multiple-sclerosis-105169https://curecurrent.com/trials/cognitive-reserve-building-activities-in-multiple-sclerosis-105170https://curecurrent.com/trials/investigation-of-the-effects-of-pilates-training-combined-with-whole-body-vibration-on-balance-and-mobility-in-individua-105171https://curecurrent.com/trials/effects-of-ocrelizumab-on-b-cell-tolerance-defect-in-relapsing-multiple-sclerosis-105172https://curecurrent.com/trials/spinal-cord-neuromodulator-by-spinex-and-scone-to-treat-neurogenic-bladder-scone-continence-clinical-study-105173https://curecurrent.com/trials/spinal-cord-monitoring-in-multiple-sclerosis-105174https://curecurrent.com/trials/serum-neurofilament-light-in-multiple-sclerosis-105175https://curecurrent.com/trials/unraveling-active-ingredients-of-neurorehabilitation-investigating-cortical-activity-during-task-oriented-exercises-105176https://curecurrent.com/trials/holter-of-movement-in-patients-with-multiple-sclerosis-in-controlled-environment-105177https://curecurrent.com/trials/improving-learning-and-memory-in-portuguese-patients-with-multiple-sclerosis-105178https://curecurrent.com/trials/holter-of-movement-in-patients-with-multiple-sclerosis-in-uncontrolled-environment-105179https://curecurrent.com/trials/periodic-leg-movements-diagnosis-in-spinal-cord-injury-actigraphy-as-an-alternative-for-polysomnography-105180https://curecurrent.com/trials/isolated-versus-combined-cognitive-and-motor-high-tech-rehabilitation-105181https://curecurrent.com/trials/acth-in-progressive-forms-of-ms-105182https://curecurrent.com/trials/safety-study-to-evaluate-immune-response-of-vaccines-in-participants-with-relapsing-forms-of-multiple-sclerosis-who-rece-105183https://curecurrent.com/trials/disability-level-and-trunk-control-in-individuals-with-multiple-sclerosis-105184https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-of-teriflunomide-in-pediatric-patients-with-relapsing-forms-of-multiple-sclerosis-105185https://curecurrent.com/trials/the-effect-of-metformin-as-an-adjuvant-therapy-on-immunological-parameters-in-egyptian-patients-with-rrms-a-pilot-study-105186https://curecurrent.com/trials/short-term-b-cell-depletion-in-relapsing-multiple-sclerosis-105187https://curecurrent.com/trials/genetics-and-environment-intersection-in-the-als-ftd-spectrum-an-italian-twins-cohort-study-with-a-multi-omics-approach-105188https://curecurrent.com/trials/covid-19-vaccine-immune-response-in-multiple-sclerosis-105189https://curecurrent.com/trials/fatigue-management-programs-for-people-with-ms-105190https://curecurrent.com/trials/a-study-of-suvorexant-in-patients-with-multiple-sclerosis-fatigue-and-insomnia-105191https://curecurrent.com/trials/efficacy-and-safety-of-oral-bosentan-on-healing-prevention-of-digital-finger-ulcers-in-patients-with-scleroderma-105192https://curecurrent.com/trials/balance-targeted-exercises-for-individuals-with-ms-105193https://curecurrent.com/trials/effectiveness-of-a-digital-health-application-for-multiple-sclerosis-levidex-105194https://curecurrent.com/trials/rel-ab-l-ty-and-val-d-ty-of-the-sup-ne-to-stand-test-w-th-multiple-sclerosis-105195https://curecurrent.com/trials/natalizumab-in-preventing-post-partum-relapses-in-multiple-sclerosis-105196https://curecurrent.com/trials/telehealth-pain-self-management-for-employed-adults-105197https://curecurrent.com/trials/predicting-epileptogenic-tubers-in-patients-with-tuberous-sclerosis-complex-105198https://curecurrent.com/trials/first-in-human-trial-in-healthy-adult-volunteers-to-evaluate-safety-tolerability-and-pk-of-lapix-study-drug-lpx-ti641-105199https://curecurrent.com/trials/extension-to-the-magnify-ms-trial-on-mavenclad-magnify-ms-extension-105200https://curecurrent.com/trials/the-gilenya-pregnancy-registry-105201https://curecurrent.com/trials/intermediate-size-expanded-access-protocol-eap-for-lp352-105202https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-fhnd1002-granules-in-healthy-adults-105203https://curecurrent.com/trials/the-effectiveness-and-safety-of-resective-epilepsy-surgery-for-tre-105204https://curecurrent.com/trials/effect-of-cladribine-treatment-on-microglial-activation-in-the-cns-105205https://curecurrent.com/trials/multimodal-imaging-of-ms-reveals-the-smoldering-inflammation-105206https://curecurrent.com/trials/multidimensional-integrated-assessment-to-test-the-efficacy-and-response-to-ozanimod-in-multiple-sclerosis-105207https://curecurrent.com/trials/study-to-evaluate-the-effectiveness-and-safety-of-ocrelizumab-in-participants-with-early-stage-relapsing-remitting-multi-105208https://curecurrent.com/trials/clinical-trial-data-set-re-use-with-statistical-methodologies-tailored-for-clinical-trials-in-rare-diseases-105209https://curecurrent.com/trials/kesimpta-ofatumumab-pregnancy-registry-105210https://curecurrent.com/trials/stem-cells-in-rapidly-evolving-active-multiple-sclerosis-105211https://curecurrent.com/trials/comparative-effectiveness-study-telerehab-versus-conventional-105212https://curecurrent.com/trials/kysa-7-a-study-of-anti-cd19-car-t-cell-therapy-in-subjects-with-refractory-primary-and-secondary-progressive-multiple-sc-105213https://curecurrent.com/trials/frequency-of-gastrointestinal-and-hepatic-manifestations-among-patients-with-multiple-sclerosis-a-clinical-hospital-base-105214https://curecurrent.com/trials/a-study-of-ipl344-in-the-treatment-of-als-patients-105215https://curecurrent.com/trials/a-follow-up-study-to-protocol-101-2-continued-treatment-by-ipl344-iv-105216https://curecurrent.com/trials/the-dancerex-proof-of-concept-study-for-chronic-neurological-disorders-105217https://curecurrent.com/trials/pilot-study-for-the-evaluation-of-the-more-stamina-in-persons-with-multiple-sclerosis-105218https://curecurrent.com/trials/observational-retrospective-multicenter-nonprofit-study-on-the-prevalence-of-renal-involvement-in-pediatric-patients-wit-105219https://curecurrent.com/trials/scleroderma-treatment-with-autologous-transplant-stat-study-105220https://curecurrent.com/trials/the-effect-of-reiki-application-on-depression-anxiety-and-physical-activity-in-patient-with-multiple-sclerosis-105221https://curecurrent.com/trials/disease-modifying-therapies-withdrawal-in-inactive-relapsing-remitting-multiple-sclerosis-patients-aged-55-and-over-twin-105222https://curecurrent.com/trials/universal-car-t-cells-in-patients-with-refractory-autoimmune-diseases-of-the-nervous-system-105223https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ocrelizumab-in-patients-with-relapsing-remitting-multiple-sclerosis-105224https://curecurrent.com/trials/retrospective-study-on-the-role-of-scfa-modulation-in-multiple-sclerosis-105225https://curecurrent.com/trials/anakinra-for-the-treatment-of-chronically-inflamed-white-matter-lesions-in-multiple-sclerosis-105226https://curecurrent.com/trials/exercise-booster-sessions-in-people-with-multiple-sclerosis-105227https://curecurrent.com/trials/functional-electrical-stimulation-cycling-for-managing-mobility-disability-in-people-with-multiple-sclerosis-105228https://curecurrent.com/trials/the-effect-of-hybrid-telerehabilitation-based-structured-exercise-programs-in-patients-with-multiple-sclerosis-105229https://curecurrent.com/trials/multiple-sclerosis-and-the-effects-of-ketogenic-diet-therapy-105230https://curecurrent.com/trials/efficacy-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-zyil1-in-patients-with-amyotrophic-lateral-scleros-105231https://curecurrent.com/trials/the-nrc-dataset-developing-a-minimum-dataset-for-multidisciplinary-rehabilitation-a-modified-e-delphi-study-105232https://curecurrent.com/trials/the-effectiveness-and-safety-of-vagus-nerve-stimulation-for-tre-105233https://curecurrent.com/trials/effectiveness-of-cladribine-tablets-in-participants-with-highly-active-relapsing-multiple-sclerosis-camelot-ms-105234https://curecurrent.com/trials/a-study-to-assess-new-participant-s-perspectives-beyond-clinical-efficacy-of-monoclonal-antibody-based-relapsing-remitti-105235https://curecurrent.com/trials/real-world-effectiveness-persistence-tolerability-and-safety-of-ofatumumab-in-clinical-practice-105236https://curecurrent.com/trials/hfs-high-fiber-supplement-in-ms-multiple-sclerosis-105237https://curecurrent.com/trials/norwegian-study-of-oral-cladribine-and-rituximab-in-multiple-sclerosis-nor-ms-105238https://curecurrent.com/trials/swiss-pediatric-inflammatory-brain-disease-registry-swiss-ped-ibraind-105239https://curecurrent.com/trials/imaging-the-interplay-between-axonal-damage-and-repair-in-multiple-sclerosis-105240https://curecurrent.com/trials/the-effect-of-yoga-on-sleep-quality-fatigue-and-physical-activity-level-of-multiple-sclerosis-105241https://curecurrent.com/trials/cannabis-as-a-complementary-treatment-in-multiple-sclerosis-105242https://curecurrent.com/trials/gut-microbiome-and-depression-105243https://curecurrent.com/trials/a-dyadic-approach-for-promoting-physical-activity-among-people-with-ms-and-their-support-partners-105244https://curecurrent.com/trials/deep-brain-stimulation-for-refractory-trigeminal-neuralgia-with-a-pontine-lesion-105245https://curecurrent.com/trials/assessing-nhs-implementation-of-an-online-resilience-training-acceptance-and-commitment-therapy-act-programme-to-prevent-105246https://curecurrent.com/trials/evaluation-of-the-effect-of-nabiximols-oromucosal-spray-on-clinical-measures-of-spasticity-in-participants-with-multiple-105247https://curecurrent.com/trials/tele-exercise-and-multiple-sclerosis-105248https://curecurrent.com/trials/resistance-training-and-corticospinal-excitability-in-multiple-sclerosis-105249https://curecurrent.com/trials/upper-extremity-function-in-multiple-sclerosis-patients-with-advanced-disability-treated-with-ocrevus-105250https://curecurrent.com/trials/a-negative-dendritic-cell-based-vaccine-for-the-treatment-of-multiple-sclerosis-a-first-in-human-clinical-trial-105251https://curecurrent.com/trials/reducing-fatigue-in-people-with-multiple-sclerosis-by-treatment-with-tens-105252https://curecurrent.com/trials/self-compassion-for-people-with-multiple-sclerosis-an-exploratory-feasibility-study-105253https://curecurrent.com/trials/implementation-of-online-mindfulness-based-stress-reduction-tailored-for-people-with-multiple-sclerosis-105254https://curecurrent.com/trials/intervention-to-reduce-perceived-cognitive-impairment-in-multiple-sclerosis-105255https://curecurrent.com/trials/validity-and-reliability-of-lower-extremity-position-test-in-patients-with-multiple-sclerosis-105256https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-reldesemtiv-in-patients-with-amyotrophic-lateral-sclerosis-als-105257https://curecurrent.com/trials/effects-of-upper-extremity-focused-neuromuscular-training-in-people-with-multiple-sclerosis-105258https://curecurrent.com/trials/cognitive-stimulation-in-patients-with-sclerosis-multiple-105259https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-monthly-long-acting-im-injection-of-80-or-40-mg-ga-depot-in-subjects-with-rrms-105260https://curecurrent.com/trials/emg-biofeedback-training-to-improve-balance-in-individuals-with-multiple-sclerosis-105261https://curecurrent.com/trials/cubii-for-exercise-in-people-with-ms-105262https://curecurrent.com/trials/effect-of-riluzole-as-a-symptomatic-approach-in-patients-with-chronic-cerebellar-ataxia-105263https://curecurrent.com/trials/b-cell-depletion-in-offspring-to-women-with-ms-under-immunomodulatory-treatment-105264https://curecurrent.com/trials/bacille-calmette-gu-rin-bcg-vaccine-in-radiologically-isolated-syndrome-ris-105265https://curecurrent.com/trials/pilot-of-the-virtual-memory-attention-and-problem-solving-skills-intervention-for-persons-with-multiple-sclerosis-ms-105266https://curecurrent.com/trials/comparison-of-vigorous-versus-low-intensity-cool-room-treadmill-training-in-people-with-multiple-sclerosis-105267https://curecurrent.com/trials/examining-the-risk-of-skin-cancer-in-multiple-sclerosis-patients-using-fingolimod-a-population-based-study-105268https://curecurrent.com/trials/an-international-multicenter-randomized-double-blind-double-masked-study-of-the-efficacy-and-safety-of-bcd-132-jsc-bioca-105269https://curecurrent.com/trials/impact-of-custom-assistive-and-adaptive-technology-in-rehabilitation-105270https://curecurrent.com/trials/light-stimulation-to-improve-visual-function-after-optic-neuritis-in-persons-with-multiple-sclerosis-105271https://curecurrent.com/trials/clinical-study-of-npc-12y-gel-in-patients-with-skin-lesions-associated-with-tsc-105272https://curecurrent.com/trials/physical-function-health-and-employment-for-people-with-multiple-sclerosis-105273https://curecurrent.com/trials/a-single-center-study-to-characterize-the-safety-and-efficacy-of-ublituximab-in-older-adults-with-relapsing-forms-of-mul-105274https://curecurrent.com/trials/providing-emotional-support-around-the-point-of-multiple-sclerosis-diagnosis-prelims-2-105275https://curecurrent.com/trials/clinical-study-of-solifenacin-succinate-in-patients-with-bladder-symptoms-due-to-spinal-cord-injury-or-multiple-sclerosi-105276https://curecurrent.com/trials/polish-version-fatigue-severity-scale-105277https://curecurrent.com/trials/study-to-investigate-lp352-in-subjects-with-developmental-and-epileptic-encephalopathies-105278https://curecurrent.com/trials/a-pilot-project-for-multifidus-muscle-evaluation-in-patients-with-multiple-sclerosis-105279https://curecurrent.com/trials/clinical-trial-assessing-temelimab-following-rituximab-treatment-in-patients-with-relapsing-forms-of-multiple-sclerosis-105280https://curecurrent.com/trials/studying-eye-movement-deficits-and-cognitive-impairment-in-patients-with-multiple-sclerosis-using-infrared-eye-tracking-105281https://curecurrent.com/trials/effect-of-functional-inspiratory-muscle-training-in-patients-with-multiple-sclerosis-105282https://curecurrent.com/trials/foot-muscles-training-in-sclerosis-105283https://curecurrent.com/trials/tsc-remote-assessment-and-intervention-105284https://curecurrent.com/trials/safety-and-efficacy-of-ct103a-cells-for-relapsed-refractory-antibody-associated-inflammatory-diseases-of-the-nervous-sys-105285https://curecurrent.com/trials/technology-assisted-conscientiousness-therapy-for-people-with-multiple-sclerosis-105286https://curecurrent.com/trials/rituximab-and-ocrelizumab-in-serum-with-multiple-sclerosis-105287https://curecurrent.com/trials/walking-and-thinking-brain-activity-during-complex-walking-in-people-with-multiple-sclerosis-105288https://curecurrent.com/trials/effects-of-individualized-training-to-reduce-fatigue-in-patients-with-newly-and-advanced-diagnosed-multiple-sclerosis-105289https://curecurrent.com/trials/mood-disorders-in-multiple-sclerosis-patients-105290https://curecurrent.com/trials/five-times-sit-to-stand-test-for-patients-with-pediatric-onset-multiple-sclerosis-105291https://curecurrent.com/trials/application-of-multiparametric-structural-and-functional-mri-in-unraveling-the-substrates-of-cognitive-impairment-and-di-105292https://curecurrent.com/trials/improving-prospective-memory-via-telehealth-105293https://curecurrent.com/trials/the-feasibility-of-frame-running-as-an-exercise-option-for-people-with-multiple-sclerosis-105294https://curecurrent.com/trials/adderall-xr-and-cognitive-impairment-in-ms-105295https://curecurrent.com/trials/effects-of-transcranial-static-magnetic-field-stimulation-tsms-in-progressive-multiple-sclerosis-105296https://curecurrent.com/trials/the-effect-of-self-acupressure-in-patients-with-multiple-sclerosis-105297https://curecurrent.com/trials/real-world-persistence-and-adherence-of-ofatumumab-compared-to-self-injectable-and-oral-dmts-in-patients-with-multiple-s-105298https://curecurrent.com/trials/effects-of-dimethyl-fumarate-on-cognitive-performance-and-brain-abnormalities-in-multiple-sclerosis-105299https://curecurrent.com/trials/functional-electrostimulation-on-the-upper-lip-in-multiple-sclerosis-105300https://curecurrent.com/trials/investigating-visuo-spatial-abilities-and-psychological-effects-in-west-nile-and-multiple-sclerosis-patients-with-a-focu-105301https://curecurrent.com/trials/investigation-of-the-effect-of-ocrelizumab-on-peripheral-lymphocyte-immunophenotypes-with-suppressive-capacity-in-ms-105302https://curecurrent.com/trials/validation-of-the-18-kilodalton-translocator-protein-tspo-as-a-novel-neuroimmunodulatory-target-105303https://curecurrent.com/trials/exercise-in-people-with-systemic-sclerosis-105304https://curecurrent.com/trials/the-effect-of-the-human-care-model-on-patients-with-multiple-sclerosis-105305https://curecurrent.com/trials/a-multicenter-study-to-assess-response-to-influenza-vaccine-in-multiple-sclerosis-participants-treated-with-ofatumumab-105306https://curecurrent.com/trials/ocrelizumab-for-preventing-clinical-multiple-sclerosis-in-individuals-with-radiologically-isolated-disease-105307https://curecurrent.com/trials/ptns-for-female-patients-suffering-from-multiple-sclerosis-105308https://curecurrent.com/trials/deuterium-metabolic-imaging-in-people-with-multiple-sclerosis-105309https://curecurrent.com/trials/validating-digital-biomarkers-to-detect-disease-activity-and-disease-progression-in-multiple-sclerosis-105310https://curecurrent.com/trials/a-systems-approach-to-understanding-disease-processes-in-multiple-sclerosis-105311https://curecurrent.com/trials/investigation-of-the-effects-of-local-vibration-applied-to-different-regions-and-spinal-stabilization-exercises-105312https://curecurrent.com/trials/botulinum-toxin-a-vs-anticholinergic-treatment-of-neurogenic-overactive-bladder-in-patients-with-multiple-sclerosis-105313https://curecurrent.com/trials/effect-of-ocrelizumab-on-cortical-lesion-accumulation-in-patients-with-ppms-oratorio-cortical-105314https://curecurrent.com/trials/pilates-yoga-and-tai-chi-exercises-effect-on-balance-and-gait-in-patients-with-multiple-sclerosis-105315https://curecurrent.com/trials/discontinuation-of-disease-modifying-therapies-dmts-in-multiple-sclerosis-ms-extension-of-the-discoms-study-105316https://curecurrent.com/trials/a-biomarker-study-to-evaluate-mn-166-in-subjects-with-amyotrophic-literal-sclerosis-als-105317https://curecurrent.com/trials/efficacy-and-safety-of-calculus-bovis-sativus-cbs-for-idiopathic-inflammatory-demyelinating-disease-cbsiniidd-105318https://curecurrent.com/trials/a-real-world-study-to-assess-the-use-of-siponimod-in-spain-to-treat-patients-with-secondary-progressive-multiple-scleros-105319https://curecurrent.com/trials/reducing-sedentary-behaviour-a-novel-opportunity-for-managing-comorbidity-in-ms-105320https://curecurrent.com/trials/ultra-high-field-brain-mri-in-multiple-sclerosis-105321https://curecurrent.com/trials/the-effect-of-iyengar-yoga-practice-on-patients-with-multiple-sclerosis-105322https://curecurrent.com/trials/validation-of-multimodal-evoked-potentials-mmep-for-predicting-disease-progression-in-multiple-sclerosis-105323https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-transitioning-patients-from-natalizumab-to-ocrelizumab-105324https://curecurrent.com/trials/measuring-consequences-of-disability-for-patients-with-multiple-sclerosis-and-caregivers-on-economic-burden-105325https://curecurrent.com/trials/the-effects-of-in-phase-bilateral-exercise-in-people-with-progressive-multiple-sclerosis-105326https://curecurrent.com/trials/the-effect-of-nurse-practitioner-np-led-care-upon-mood-in-people-with-multiple-sclerosis-105327https://curecurrent.com/trials/multiple-sclerosis-simvastatin-trial-2-105328https://curecurrent.com/trials/using-patient-reported-outcomes-to-improve-the-care-of-people-with-multiple-sclerosis-105329https://curecurrent.com/trials/a-study-of-end-of-dose-phenomena-in-subcutaneous-natalizumab-treated-multiple-sclerosis-ms-participants-105330https://curecurrent.com/trials/enhancing-pelvic-floor-function-with-transcranial-magnetic-and-tibial-nerve-stimulation-for-neurogenic-bladder-in-ms-105331https://curecurrent.com/trials/upper-extremity-motor-imagery-functional-skills-and-quality-of-life-in-patients-with-multiple-sclerosis-105332https://curecurrent.com/trials/virtual-reality-in-the-treatment-of-pelvic-floor-dysfunction-in-women-with-multiple-sclerosis-105333https://curecurrent.com/trials/safety-and-effectiveness-of-generic-fingolimod-sphingomod-hikma-in-patients-with-relapsing-remitting-multiple-sclerosis-105334https://curecurrent.com/trials/multiple-sclerosis-treatment-with-autologous-hematopoietic-stem-cell-transplantation-in-the-netherlands-105335https://curecurrent.com/trials/positive-psychological-interventions-for-patients-with-multiple-sclerosis-105336https://curecurrent.com/trials/the-ms-link-outcomes-study-105337https://curecurrent.com/trials/neural-mobilization-on-multiple-sclerosis-105338https://curecurrent.com/trials/calorie-restriction-in-multiple-sclerosis-105339https://curecurrent.com/trials/preventing-epilepsy-using-vigabatrin-in-infants-with-tuberous-sclerosis-complex-105340https://curecurrent.com/trials/non-invasive-electrical-spinal-cord-stimulation-to-restore-upper-extremity-function-in-multiple-sclerosis-105341https://curecurrent.com/trials/a-phase-iiib-multicenter-international-study-to-evaluate-the-efficacy-safety-and-tolerability-of-ek-12-in-patients-with-105342https://curecurrent.com/trials/tolebrutinib-a-brain-penetrant-bruton-s-tyrosine-kinase-inhibitor-for-the-modulation-of-chronically-inflamed-white-matte-105343https://curecurrent.com/trials/intermittent-fasting-and-mediterranean-diet-in-patient-with-multiple-sclerosis-105344https://curecurrent.com/trials/assessing-the-cognitive-benefits-of-ozanimod-and-their-brain-biomarkers-in-ms-105345https://curecurrent.com/trials/a-study-to-investigate-safety-of-gs-248-and-efficacy-on-raynauds-phenomenon-in-systemic-sclerosis-105346https://curecurrent.com/trials/sun-yat-sen-cohort-of-cns-idiopathic-inflammatory-demyelinating-diseases-105347https://curecurrent.com/trials/grey-matter-damage-at-the-earliest-phase-of-multiple-sclerosis-a-longitudinal-7t-mri-study-105348https://curecurrent.com/trials/mri-study-of-the-mechanisms-underlying-irreversible-disability-in-multiple-sclerosis-105349https://curecurrent.com/trials/evaluating-multiple-sclerosis-patients-showing-a-genomic-signature-of-therapy-response-105350https://curecurrent.com/trials/kesimpta-pregnancy-and-infant-safety-study-using-real-world-data-105351https://curecurrent.com/trials/clinical-investigation-to-validate-the-safety-and-performance-of-the-able-exoskeleton-device-for-individuals-with-multip-105352https://curecurrent.com/trials/insulin-resistance-in-egyptian-patients-with-multiple-sclerosis-105353https://curecurrent.com/trials/investigation-of-the-effectiveness-of-craniosacral-therapy-in-patients-with-multiple-sclerosis-105354https://curecurrent.com/trials/influence-of-anaesthesia-type-on-multiple-sclerosis-relapse-105355https://curecurrent.com/trials/study-to-assess-changes-in-immunoglobulins-in-patients-with-relapsing-multiple-sclerosis-treated-with-anti-cd20-therapie-105356https://curecurrent.com/trials/function-magnetic-resonance-imaging-to-assess-two-therapeutic-strategies-in-multiple-sclerosis-neurorehem-105357https://curecurrent.com/trials/development-of-camera-based-gait-quality-measure-for-persons-with-multiple-sclerosis-105358https://curecurrent.com/trials/effect-of-a-fasting-mimicking-diet-on-patients-with-multiple-sclerosis-fmdms-105359https://curecurrent.com/trials/neurostatus-smartcare-in-comparison-to-standard-neurostatus-edss-105360https://curecurrent.com/trials/fatigability-in-persons-with-multiple-sclerosis-inputs-from-cognition-walking-and-coordination-105361https://curecurrent.com/trials/the-effect-of-cognitive-exercise-on-upper-extremity-functions-balance-and-cognitive-functions-in-multiple-sclerosis-105362https://curecurrent.com/trials/task-specific-training-for-advanced-multiple-sclerosis-105363https://curecurrent.com/trials/eccentric-exercise-and-fatigue-in-multiple-sclerosis-105364https://curecurrent.com/trials/the-effect-of-music-and-progressive-relaxation-exercise-on-fatigue-and-sleep-in-multiple-sclerosis-105365https://curecurrent.com/trials/measuring-silent-disease-progression-in-multiple-sclerosis-with-a-multimodal-approach-105366https://curecurrent.com/trials/effectiveness-of-acupuncture-treatment-applied-in-addition-to-the-rehabilitation-program-in-multiple-sclerosis-patients-105367https://curecurrent.com/trials/a-comprehensive-assessment-of-trunk-scapula-and-upper-limb-in-neurological-patients-reliability-validity-and-interrelate-105368https://curecurrent.com/trials/reliability-and-validity-of-outcome-measures-for-pain-in-multiple-sclerosis-105369https://curecurrent.com/trials/comparing-transanal-irrigation-with-navina-smart-vs-standard-bowel-care-in-patients-with-multiple-sclerosis-105370https://curecurrent.com/trials/comparison-of-diagnostic-performances-of-3d-flair-dir-and-psir-sequences-in-optic-neuritis-105371https://curecurrent.com/trials/computer-assisted-cognitive-rehabilitation-for-persons-with-multiple-sclerosis-105372https://curecurrent.com/trials/cognitive-remediation-augmented-with-transcranial-direct-current-stimulation-tdcs-105373https://curecurrent.com/trials/gait-analysis-in-multiple-sclerosis-patients-105374https://curecurrent.com/trials/pregnancy-cohort-in-multiple-sclerosis-ms-105375https://curecurrent.com/trials/effectiveness-of-task-specific-home-exercise-program-105376https://curecurrent.com/trials/strategies-for-adaptive-follow-up-and-evaluation-guiding-use-of-indicators-for-de-escalation-in-multiple-sclerosis-105377https://curecurrent.com/trials/telerehabilitation-in-progressive-multiple-sclerosis-105378https://curecurrent.com/trials/remote-evaluation-of-mind-diet-105379https://curecurrent.com/trials/effects-of-resistance-training-in-multiple-sclerosis-a-randomized-trial-105380https://curecurrent.com/trials/pet-imaging-of-cyclooxygenase-in-multiple-sclerosis-105381https://curecurrent.com/trials/efficacy-of-alpha-blockers-tamsulosin-in-the-treatment-of-symptomatic-dysuria-in-multiple-sclerosis-in-women-105382https://curecurrent.com/trials/pelvic-floor-disorders-in-multiple-sclerosis-patients-105383https://curecurrent.com/trials/a-study-to-investigate-the-radiological-onset-of-action-after-treatment-initiation-with-subcutaneous-sc-natalizumab-in-p-105384https://curecurrent.com/trials/safety-and-tolerability-of-conversion-from-oral-injectable-or-infusion-disease-modifying-therapies-to-dose-titrated-oral-105385https://curecurrent.com/trials/exploring-the-immune-response-to-sars-cov-2-modrna-vaccines-in-patients-with-secondary-progressive-multiple-sclerosis-am-105386https://curecurrent.com/trials/cerebellar-tdcs-and-balance-training-in-pwms-105387https://curecurrent.com/trials/a-study-to-assess-covid-19-vaccination-immune-response-in-multiple-sclerosis-patients-treated-with-ofatumumab-105388https://curecurrent.com/trials/characteristics-adherence-and-persistence-among-multiple-sclerosis-patients-treated-with-disease-modifying-therapies-105389https://curecurrent.com/trials/the-effect-of-cigarette-smoke-on-sleep-quality-and-physical-activity-in-people-with-multiple-sclerosis-105390https://curecurrent.com/trials/copaxone-subcutaneous-injection-syringe-special-drug-use-result-investigation-all-case-investigation-prevention-of-relap-105391https://curecurrent.com/trials/a-study-to-evaluate-efficacy-safety-and-tolerability-of-eid-of-natalizumab-bg00002-in-participants-with-rrms-switching-f-105392https://curecurrent.com/trials/an-observational-biomarker-study-in-multiple-sclerosis-ms-patients-105393https://curecurrent.com/trials/low-load-blood-flow-restriction-on-patients-with-multiple-sclerosis-105394https://curecurrent.com/trials/enhancing-quality-of-life-in-ms-patients-through-tailored-therapeutic-education-105395https://curecurrent.com/trials/trunk-rehabilitation-compared-to-core-stability-in-patients-with-multiple-sclerosis-105396https://curecurrent.com/trials/next-gen-ms-feed-forward-pro-data-for-ms-research-105397https://curecurrent.com/trials/exploring-the-efficacy-and-safety-of-siponimod-in-patients-with-secondary-progressive-multiple-sclerosis-expand-105398https://curecurrent.com/trials/high-intensity-dynamic-stability-gait-training-in-people-with-multiple-sclerosis-105399https://curecurrent.com/trials/national-multicentric-registry-study-on-neuroimmunological-diseases-in-china-105400https://curecurrent.com/trials/study-to-explore-the-mechanism-of-action-of-ocrelizumab-and-b-cell-biology-in-participants-with-relapsing-multiple-scler-105401https://curecurrent.com/trials/productive-value-of-sonographic-measurement-of-optic-nerve-in-transitional-multiple-105402https://curecurrent.com/trials/potentials-quality-of-life-among-patients-with-amyotrophic-lateral-sclerosis-105403https://curecurrent.com/trials/a-proof-of-concept-study-to-correlate-retinal-nerve-fiber-layer-changes-in-patients-with-multiple-sclerosis-treated-with-105404https://curecurrent.com/trials/natalizumab-subcutaneous-immunogenicity-and-safety-study-105405https://curecurrent.com/trials/canadian-multicenter-observational-study-of-tysabri-in-early-relapsing-remitting-multiple-sclerosis-participants-105406https://curecurrent.com/trials/mechanistic-study-of-ocrevus-105407https://curecurrent.com/trials/cognition-and-hrqol-in-adults-with-highly-active-rms-in-year-3-and-4-after-initial-mavenclad-dose-clarify-ms-extension-105408https://curecurrent.com/trials/rex-robot-assisted-rehabilitation-to-enhance-balance-and-mobility-for-people-with-multiple-sclerosis-clinical-and-biomar-105409https://curecurrent.com/trials/the-efficacy-of-tele-rehabilitation-based-task-specific-training-for-cognitive-function-improvement-105410https://curecurrent.com/trials/a-study-to-compare-efficacy-pharmacokinetics-pharmacodynamics-and-safety-of-ct-p53-and-ocrevus-in-patients-with-relapsin-105411https://curecurrent.com/trials/prebiotic-vs-probiotic-in-multiple-sclerosis-105412https://curecurrent.com/trials/serial-collection-of-primary-progressive-multiple-sclerosis-participants-in-the-murdock-study-105413https://curecurrent.com/trials/the-effects-of-two-types-of-t-dcs-stimulation-on-robot-assisted-gait-training-in-patients-with-multiple-sclerosis-105414https://curecurrent.com/trials/long-term-effectiveness-and-safety-evaluation-of-ocrelizumab-105415https://curecurrent.com/trials/use-of-a-smartphone-application-to-predict-the-prognosis-in-patients-with-newly-diagnosed-multiple-sclerosis-105416https://curecurrent.com/trials/use-of-audio-recordings-of-self-hypnosis-and-meditation-for-fatigue-management-in-multiple-sclerosis-105417https://curecurrent.com/trials/trial-of-ehealth-wellness-behavioral-interventions-and-patient-reported-outcomes-105418https://curecurrent.com/trials/a-study-to-explore-association-patterns-between-digital-outcome-assessments-from-the-konectom-platform-and-magnetic-reso-105419https://curecurrent.com/trials/a-study-for-tysabri-participant-preference-105420https://curecurrent.com/trials/effects-of-acthar-on-advanced-mri-surrogate-markers-of-disease-activity-and-on-comprehensive-immune-signature-during-ms-105421https://curecurrent.com/trials/the-effect-of-a-mindfulness-based-stress-reduction-program-in-patients-with-multiple-sclerosis-105422https://curecurrent.com/trials/prescription-drug-safety-and-effectiveness-in-multiple-sclerosis-105423https://curecurrent.com/trials/home-based-balance-training-in-adults-with-multiple-sclerosis-105424https://curecurrent.com/trials/stopping-tsc-onset-and-progression-2-epilepsy-prevention-in-tsc-infants-105425https://curecurrent.com/trials/post-authorization-safety-study-for-assessment-of-pregnancy-outcomes-in-patients-treated-with-mayzent-105426https://curecurrent.com/trials/serum-neurofilament-light-chain-and-gfap-levels-in-patients-from-the-ofsep-cohort-at-different-landmarks-of-multiple-scl-105427https://curecurrent.com/trials/mapping-the-longitudinal-multidimensional-impact-of-ms-in-relation-to-variables-indicative-of-neurological-reserve-105428https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-lower-limb-spasticity-in-multiple-sclerosis-patients-105429https://curecurrent.com/trials/remote-ischemic-conditioning-in-ppms-105430https://curecurrent.com/trials/effects-of-a-combined-supplementation-of-conjugated-linoleic-acid-cla-and-probiotics-vivomixx-as-add-on-to-a-first-line-105431https://curecurrent.com/trials/safety-and-effectiveness-of-nabiximols-oromucosal-spray-as-add-on-therapy-in-participants-with-spasticity-due-to-multipl-105432https://curecurrent.com/trials/be-cool-an-innovative-and-holistic-psychoeducational-program-for-multiple-sclerosis-individuals-105433https://curecurrent.com/trials/ahsct-with-fludarabine-and-cyclophosphamide-based-conditioning-regimes-in-patients-with-multiple-sclerosis-105434https://curecurrent.com/trials/improving-the-effect-of-multiple-sclerosis-drugs-by-chronobiology-105435https://curecurrent.com/trials/telerehabilitation-in-multiple-sclerosis-105436https://curecurrent.com/trials/a-study-to-assess-the-effectiveness-and-safety-of-mayzent-in-chinese-patients-with-relapsing-forms-of-multiple-sclerosis-105437https://curecurrent.com/trials/the-reliability-of-the-nine-hole-peg-test-in-patients-with-multiple-sclerosis-105438https://curecurrent.com/trials/study-to-evaluate-efficacy-safety-and-tolerability-of-imu-838-in-patients-with-progressive-multiple-sclerosis-105439https://curecurrent.com/trials/effects-of-balance-exercises-performed-with-different-visual-stimuli-105440https://curecurrent.com/trials/awareness-of-osteoporosis-in-multiple-sclerosis-patients-105441https://curecurrent.com/trials/evaluation-of-the-influence-of-a-core-muscle-control-based-rehabilitation-program-patients-with-multiple-sclerosis-105442https://curecurrent.com/trials/running-title-walking-to-music-and-in-silence-on-a-treadmill-105443https://curecurrent.com/trials/traditional-versus-progressive-robot-assisted-gait-training-in-people-with-multiple-sclerosis-and-severe-gait-disability-105444https://curecurrent.com/trials/mri-trial-to-explore-the-efficacy-and-safety-of-imu-838-in-relapsing-remitting-multiple-sclerosis-emphasis-105445https://curecurrent.com/trials/speech-in-noise-discrimination-skills-in-multiple-sclerosis-patients-105446https://curecurrent.com/trials/efficacy-and-safety-of-circadin-in-the-treatment-of-sleep-disturbances-in-children-with-neurodevelopment-disabilities-105447https://curecurrent.com/trials/effects-of-head-and-neck-cooling-and-heating-on-fatigue-in-multiple-sclerosis-and-healthy-men-105448https://curecurrent.com/trials/creating-satisfying-engagement-in-daily-life-through-coaching-for-people-with-multiple-sclerosis-105449https://curecurrent.com/trials/effects-of-transcutaneous-spinal-direct-current-stimulation-on-mobility-in-cases-with-multiple-sclerosis-105450https://curecurrent.com/trials/study-to-assess-the-safety-and-efficacy-of-an-it-administration-of-scm-010-in-spms-105451https://curecurrent.com/trials/natalizumab-and-chronic-inflammation-105452https://curecurrent.com/trials/kappa-index-versus-csf-oligoclonal-bands-in-diagnosis-of-ms-and-prediction-of-disease-activity-105453https://curecurrent.com/trials/severe-acute-respiratory-syndrome-coronavirus-type-2-sars-cov-2-related-multiple-sclerosis-ms-vaccination-study-105454https://curecurrent.com/trials/exopulse-mollii-suit-motor-function-multiple-sclerosis-exosep-2-105455https://curecurrent.com/trials/cognitive-rehabilitation-for-people-with-multiple-sclerosis-105456https://curecurrent.com/trials/improving-social-cognition-and-social-behaviour-in-various-brain-disorders-105457https://curecurrent.com/trials/evaluate-the-safety-and-feasibility-of-allogeneic-mesenchymal-stem-cells-in-patients-with-multiple-sclerosis-105458https://curecurrent.com/trials/trekking-poles-to-aid-multiple-sclerosis-gait-impairment-105459https://curecurrent.com/trials/b-cell-differentiation-in-ms-105460https://curecurrent.com/trials/immunogenicity-of-the-recombinant-zoster-vaccine-in-multiple-sclerosis-patients-105461https://curecurrent.com/trials/orofacial-pain-in-multiple-sclerosis-105462https://curecurrent.com/trials/tysabri-observational-program-105463https://curecurrent.com/trials/mir-142-3p-as-potential-biomarker-of-synaptopathy-in-ms-105464https://curecurrent.com/trials/role-of-ada-snps-in-subjects-with-relapsing-multiple-sclerosis-rms-105465https://curecurrent.com/trials/decisive-diagnose-using-the-central-vein-sign-v1-0-105466https://curecurrent.com/trials/time-restricted-eating-outcomes-in-multiple-sclerosis-105467https://curecurrent.com/trials/a-study-of-pirtobrutinib-ly3527727-loxo-305-versus-placebo-in-participants-with-relapsing-multiple-sclerosis-105468https://curecurrent.com/trials/tear-analysis-by-isoelectric-focusing-in-clinically-isolated-syndrome-as-multiple-sclerosis-criterion-105469https://curecurrent.com/trials/therapeutic-adherence-of-multiple-sclerosis-patients-105470https://curecurrent.com/trials/ifenprodil-as-a-remyelinating-repurposed-drug-in-multiple-sclerosis-105471https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-ocrelizumab-on-immune-responses-in-participants-with-relapsing-forms-of-multiple-scle-105472https://curecurrent.com/trials/a-reeducation-program-to-effort-to-improve-the-walking-of-multiple-sclerosis-patients-105473https://curecurrent.com/trials/a-survey-to-evaluate-early-experience-from-patient-and-care-partner-on-injection-and-device-for-kesimpta-indicated-for-m-105474https://curecurrent.com/trials/trunk-control-and-disability-in-persons-with-multiple-sclerosis-105475https://curecurrent.com/trials/acceptability-and-feasibility-of-transcranial-magnetic-stimulation-tms-for-depression-in-multiple-sclerosis-105476https://curecurrent.com/trials/the-exposition-study-105477https://curecurrent.com/trials/assessing-the-role-of-mitochondrial-dysfunction-in-primary-progressive-multiple-sclerosis-105478https://curecurrent.com/trials/tele-assessment-and-face-to-face-evaluation-of-balance-in-ms-105479https://curecurrent.com/trials/social-and-moral-cognition-in-multiple-sclerosis-105480https://curecurrent.com/trials/non-invasive-spinal-cortical-and-sensorimotor-biomarkers-in-motor-neurone-disease-105481https://curecurrent.com/trials/tysabri-observational-cohort-study-multiple-sclerosis-ms-registries-105482https://curecurrent.com/trials/cold-exposure-with-controlled-breathing-and-meditation-in-patients-with-multiple-sclerosis-cobrams-105483https://curecurrent.com/trials/transcutaneous-posterior-tibial-nerve-stimulation-in-patients-with-multiple-sclerosis-related-urge-incontinence-105484https://curecurrent.com/trials/effects-of-cladribine-tablets-on-the-pk-of-microgynon-105485https://curecurrent.com/trials/remote-evaluation-in-patients-with-multiple-sclerosis-105486https://curecurrent.com/trials/observational-study-of-a-novel-peri-infusion-regimen-on-the-infusion-associated-reactions-with-alemtuzumab-infusion-in-p-105487https://curecurrent.com/trials/targeting-subclinical-motor-and-cognitive-impairment-in-patients-with-early-onset-multiple-sclerosis-105488https://curecurrent.com/trials/pilates-4ms-pilates-intervention-for-multiple-sclerosis-105489https://curecurrent.com/trials/a-study-of-ocrelizumab-in-comparison-with-interferon-beta-1a-rebif-in-participants-with-relapsing-multiple-sclerosis-105490https://curecurrent.com/trials/imcy-0141-safety-and-efficacy-in-multiple-sclerosis-isemis-study-105491https://curecurrent.com/trials/e-based-physical-exercise-in-patients-with-multiple-sclerosis-and-comorbidity-105492https://curecurrent.com/trials/study-on-the-effectiveness-of-egb-761-vs-placebo-used-for-cognitive-impairment-in-patients-with-multiple-sclerosis-105493https://curecurrent.com/trials/effects-of-a-multiple-sclerosis-relapse-therapy-on-offspring-neurocognitive-development-and-behaviour-105494https://curecurrent.com/trials/multi-center-database-registry-to-study-thalamus-changes-using-ai-in-ms-105495https://curecurrent.com/trials/biomechanical-characterization-of-the-locomotion-in-multiple-sclerosis-patients-105496https://curecurrent.com/trials/the-regulatory-role-of-mirna-27-follistatin-like-protein-1-gene-in-multiple-scelerosis-105497https://curecurrent.com/trials/comparing-risk-and-severity-of-irrs-in-patients-premedicated-with-cetirizine-vs-diphenhydramine-prior-to-ocrelizumab-105498https://curecurrent.com/trials/a-study-of-ocrelizumab-in-comparison-with-interferon-beta-1a-rebif-in-participants-with-relapsing-multiple-sclerosis-105499https://curecurrent.com/trials/an-examination-of-cognitive-fatigue-using-functional-neuroimaging-105500https://curecurrent.com/trials/the-efficacy-of-pulse-therapy-in-acute-relapse-in-multiple-sclerosis-patients-105501https://curecurrent.com/trials/online-physical-activity-tracking-in-patients-with-multiple-sclerosis-105502https://curecurrent.com/trials/teleassessment-in-ataxic-multiple-sclerosis-105503https://curecurrent.com/trials/meningeal-inflammation-on-7t-mri-as-a-tool-for-measuring-and-predicting-ocrelizumab-response-in-multiple-sclerosis-105504https://curecurrent.com/trials/effects-of-yoga-practice-in-multiple-sclerosis-patients-a-multidimensional-approach-105505https://curecurrent.com/trials/assessment-of-nfl-and-gfap-levels-atrophy-of-the-macula-gcc-by-oct-and-whole-brain-atrophy-by-mri-to-predict-evolution-o-105506https://curecurrent.com/trials/phase-1-2-study-to-evaluate-the-safety-and-efficacy-of-ata188-in-subjects-with-progressive-multiple-sclerosis-105507https://curecurrent.com/trials/pilates-training-in-multiple-sclerosis-105508https://curecurrent.com/trials/robotics-for-mobility-rehabilitation-in-ms-105509https://curecurrent.com/trials/increasing-physical-activity-for-adults-with-multiple-sclerosis-ms-105510https://curecurrent.com/trials/the-effect-of-dual-task-on-upper-extremity-functions-in-multiple-sclerosis-patients-105511https://curecurrent.com/trials/rrms-disease-progression-and-myeloid-profiling-after-bone-marrow-transplantation-and-second-line-therapies-105512https://curecurrent.com/trials/effectiveness-of-ttns-in-ms-patients-with-lower-urinary-track-symptoms-105513https://curecurrent.com/trials/exercise-effects-in-multiple-sclerosis-105514https://curecurrent.com/trials/study-evaluating-safety-and-tolerability-of-escalating-single-and-multiple-doses-of-pipe-791-and-food-effect-in-healthy-105515https://curecurrent.com/trials/acceptance-and-commitment-therapy-in-tuberous-sclerosis-complex-105516https://curecurrent.com/trials/head-circumference-growth-in-children-who-develop-multiple-sclerosis-later-in-life-105517https://curecurrent.com/trials/the-impact-of-parasitic-infection-on-multiple-sclerosis-and-nephrotic-syndrome-105518https://curecurrent.com/trials/long-term-special-drug-use-results-surveillance-for-mayzent-in-spms-patients-105519https://curecurrent.com/trials/increasing-diagnosis-rates-while-reducing-examination-time-can-mr-fingerprinting-deliver-on-its-promise-105520https://curecurrent.com/trials/efficacy-and-safety-of-rapamycin-versus-vigabatrin-in-the-prevention-of-tuberous-sclerosis-complex-symptoms-in-infants-105521https://curecurrent.com/trials/in-phase-bilateral-exercises-in-people-with-relapsing-remitting-multiple-sclerosis-105522https://curecurrent.com/trials/emreserva-to-enhance-cognitive-reserve-in-multiple-sclerosis-105523https://curecurrent.com/trials/safety-and-tolerability-of-isx-isoxsuprine-hcl-in-ms-relapses-105524https://curecurrent.com/trials/ms-researchbiomarkers-105525https://curecurrent.com/trials/resting-postural-tremor-in-multiple-sclerosis-105526https://curecurrent.com/trials/validation-of-the-french-adaptation-of-the-mswdq-23-questionnaire-105527https://curecurrent.com/trials/epidemiological-characteristics-of-covid-19-in-patients-with-ms-or-nmo-105528https://curecurrent.com/trials/study-of-tysabri-in-early-relapsing-remitting-multiple-sclerosis-participants-105529https://curecurrent.com/trials/study-of-brain-activations-and-physiological-responses-using-neurobiofeedback-in-patients-with-multiple-sclerosis-105530https://curecurrent.com/trials/study-of-empathy-in-ms-105531https://curecurrent.com/trials/efficacy-and-tolerability-of-ap707-in-patients-with-chronic-pain-due-to-central-neuropathy-of-any-genesis-105532https://curecurrent.com/trials/long-term-efficacy-and-tolerability-of-ap707-in-patients-with-chronic-pain-due-to-central-neuropathy-of-any-genesis-105533https://curecurrent.com/trials/a-multi-site-open-label-extension-trial-of-oral-rpc1063-in-relapsing-multiple-sclerosis-105534https://curecurrent.com/trials/gray-matter-demyelination-in-primary-progressive-ms-at-7t-105535https://curecurrent.com/trials/onset-of-lower-urinary-tract-symptoms-in-multiple-sclerosis-patients-105536https://curecurrent.com/trials/covid-19-vaccine-response-in-treated-ms-patients-105537https://curecurrent.com/trials/gut-microbiota-composition-cognitive-function-and-physical-fitness-in-multiple-sclerosis-patients-105538https://curecurrent.com/trials/identifying-and-managing-psychological-distress-in-multiple-sclerosis-the-compass-ms-study-105539https://curecurrent.com/trials/preventing-the-progression-of-multiple-sclerosis-early-rehabilitative-treatment-and-multimodal-assessment-part-a-105540https://curecurrent.com/trials/a-study-to-determine-the-effect-of-ocrelizumab-on-leptomeningeal-inflammation-in-multiple-sclerosis-105541https://curecurrent.com/trials/the-effect-of-autologous-hematopoietic-stem-cell-transplantation-on-the-lower-urinary-tract-function-related-to-qol-in-m-105542https://curecurrent.com/trials/combined-sensitivity-and-specificity-of-cortical-lesions-and-central-vein-sign-for-ms-diagnosis-and-differential-diagnos-105543https://curecurrent.com/trials/exopulse-mollii-suit-spasticity-muscular-oxygenation-multiple-sclerosis-ennox-2-105544https://curecurrent.com/trials/therapeutic-monitoring-of-drugs-used-in-the-treatment-of-multiple-sclerosis-105545https://curecurrent.com/trials/assessment-of-tdcs-induced-neuronal-responses-in-multiple-sclerosis-ms-with-advanced-mri-105546https://curecurrent.com/trials/at-home-gait-assessment-105547https://curecurrent.com/trials/evaluation-of-muscle-oxidative-capacity-relationship-with-muscular-endurance-fatigue-multiple-sclerosis-105548https://curecurrent.com/trials/cardiovascular-fitness-of-patients-with-multiple-sclerosis-effect-of-exercise-on-fatigue-and-depression-105549https://curecurrent.com/trials/intermittent-fasting-in-multiple-sclerosis-105550https://curecurrent.com/trials/safety-of-exposure-to-natalizumab-during-pregnancy-105551https://curecurrent.com/trials/efficacy-of-cholecalciferol-vitamin-d3-for-delaying-the-diagnosis-of-ms-after-a-clinically-isolated-syndrome-105552https://curecurrent.com/trials/nicotinamide-riboside-supplementation-in-progressive-multiple-sclerosis-105553https://curecurrent.com/trials/a-study-of-ocrelizumab-in-participants-with-primary-progressive-multiple-sclerosis-105554https://curecurrent.com/trials/relaxahead-for-headache-patients-phase-ii-105555https://curecurrent.com/trials/ex-plissit-model-based-counseling-on-sexual-function-and-sexual-satisfaction-105556https://curecurrent.com/trials/neurofilament-light-chain-as-diagnostic-and-prognostic-marker-in-na-ve-multiple-sclerosis-patients-105557https://curecurrent.com/trials/a-multicenter-observational-study-to-evaluate-pediatric-multiple-sclerosis-in-brazil-105558https://curecurrent.com/trials/multiple-sclerosis-prediction-and-monitoring-of-progression-study-105559https://curecurrent.com/trials/efficacy-of-square-stepping-exercises-in-individuals-with-multiple-sclerosis-105560https://curecurrent.com/trials/effect-of-galvanic-vestibular-stimulation-on-cortical-excitability-and-hand-dexterity-in-multiple-sclerosis-patients-105561https://curecurrent.com/trials/effects-of-oral-cladribine-on-remyelination-and-inflammation-in-multiple-sclerosis-patients-105562https://curecurrent.com/trials/ms-spinal-mobilisation-study-105563https://curecurrent.com/trials/clinical-presentation-and-renal-outcome-of-patients-with-tuberous-sclerosis-complex-and-or-renal-angiomyolipoma-in-the-g-105564https://curecurrent.com/trials/ripc-on-activity-fatigue-and-gait-in-ms-105565https://curecurrent.com/trials/tdcs-to-enhance-cognitive-training-in-multiple-sclerosis-105566https://curecurrent.com/trials/understanding-magnetic-resonance-imaging-in-multiple-sclerosis-105567https://curecurrent.com/trials/ischemic-preconditioning-exercise-tolerance-and-multiple-sclerosis-105568https://curecurrent.com/trials/finding-patterns-in-clinical-study-experiences-of-multiple-sclerosis-patients-105569https://curecurrent.com/trials/trpms-to-improve-mobility-and-depression-in-multiple-sclerosis-105570https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-elezanumab-when-added-to-standard-of-care-in-relapsing-forms-of-multiple-sc-105571https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-elezanumab-when-added-to-standard-of-care-in-progressive-forms-of-multiple-105572https://curecurrent.com/trials/the-impact-of-body-weight-on-clinical-and-immunological-outcomes-in-relapse-remitting-multiple-sclerosis-patients-105573https://curecurrent.com/trials/evaluation-of-the-reproducibility-of-the-measurement-of-the-qsm-signal-quantitative-susceptibility-mapping-105574https://curecurrent.com/trials/performance-evaluation-of-a-3d-psir-sequence-in-mri-at-1-5t-105575https://curecurrent.com/trials/evaluation-of-the-presence-and-effects-of-kinesiophobia-in-multiple-sclerosis-105576https://curecurrent.com/trials/the-effect-of-the-nurses-support-program-on-fatigue-in-ms-patient-105577https://curecurrent.com/trials/an-online-lifestyle-modification-course-for-people-with-multiple-sclerosis-105578https://curecurrent.com/trials/ocrelizumab-effects-on-the-metabolome-in-ms-105579https://curecurrent.com/trials/amantadine-and-transcranial-magnetic-stimulation-for-treating-fatigue-in-multiple-sclerosis-105580https://curecurrent.com/trials/a-multi-center-open-label-long-term-extension-study-of-cnm-au8-in-patients-with-stable-relapsing-multiple-sclerosis-105581https://curecurrent.com/trials/the-effects-of-action-observation-therapy-aot-on-balance-and-gait-in-patients-with-multiple-sclerosis-105582https://curecurrent.com/trials/comparative-study-of-high-efficacy-disease-modifying-treatment-of-relapsing-multiple-sclerosis-105583https://curecurrent.com/trials/cogms-a-real-world-study-into-cognitive-impairment-in-people-with-multiple-sclerosis-105584https://curecurrent.com/trials/exploring-accessible-beauty-for-individuals-with-upper-extremity-deficits-105585https://curecurrent.com/trials/fecal-microbiota-transplantation-after-autologous-hsct-in-patients-with-multiple-sclerosis-105586https://curecurrent.com/trials/multiparametric-assessment-to-investigate-prognostic-factors-for-disease-evolution-a-nd-evolutionary-patterns-of-cogniti-105587https://curecurrent.com/trials/strengthening-mental-abilities-with-relational-training-smart-in-multiple-sclerosis-ms-a-feasibility-trial-105588https://curecurrent.com/trials/artificial-intelligence-in-predicting-progression-in-multiple-sclerosis-study-105589https://curecurrent.com/trials/safety-and-efficacy-of-repeated-administration-of-nurown-msc-ntf-cells-in-participants-with-progressive-ms-105590https://curecurrent.com/trials/non-invasive-transcranial-electrical-stimulation-in-ms-105591https://curecurrent.com/trials/effectiveness-of-dry-needling-for-improving-gait-in-the-patient-with-multiple-sclerosis-105592https://curecurrent.com/trials/studies-in-patients-with-tuberous-sclerosis-complex-105593https://curecurrent.com/trials/validation-of-a-novel-instrument-task-for-assessing-upper-limb-105594https://curecurrent.com/trials/multiple-sclerosis-pelvic-floor-telerehabilitation-105595https://curecurrent.com/trials/outcomes-of-group-dance-and-movement-training-in-ambulatory-ms-patients-105596https://curecurrent.com/trials/a-study-of-mk-2225-ace-1334-in-participants-with-systemic-sclerosis-with-and-without-interstitial-lung-disease-mk-2225-0-105597https://curecurrent.com/trials/hematopoietic-stem-cell-transplantation-for-treatment-of-multiple-sclerosis-in-sweden-105598https://curecurrent.com/trials/video-games-therapy-on-balance-and-cognitive-functions-in-mild-to-moderate-impaired-multiple-sclerosis-patients-105599https://curecurrent.com/trials/blood-flow-restriction-training-in-multiple-sclerosis-105600https://curecurrent.com/trials/a-community-wellness-program-for-adults-living-with-long-term-physical-disability-105601https://curecurrent.com/trials/protection-against-severe-coronavirus-disease-2019-in-patients-with-multiple-sclerosis-stratified-according-to-disease-m-105602https://curecurrent.com/trials/vibration-training-for-preventing-falls-in-healthy-population-and-multiple-sclerosis-105603https://curecurrent.com/trials/the-effects-of-fes-in-a-variety-of-walking-conditions-in-people-with-ms-105604https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-ozanimod-exposure-during-pregnancy-in-women-with-multiple-sclerosis-and-their-infants-105605https://curecurrent.com/trials/effect-of-cooling-on-balance-performance-in-multiple-sclerosis-105606https://curecurrent.com/trials/optimal-conditioning-regimen-for-autologous-transplantation-of-relapsing-remitting-multiple-sclerosis-105607https://curecurrent.com/trials/phase-ii-clinical-trial-of-och-ncnp1-105608https://curecurrent.com/trials/multiple-sclerosis-self-monitoring-study-105609https://curecurrent.com/trials/implementation-of-a-novel-functional-eye-tracking-biomarker-for-multiple-sclerosis-105610https://curecurrent.com/trials/vaccine-generated-immunity-in-ocrelizumab-treated-patients-longitudinal-assessments-viola-105611https://curecurrent.com/trials/improving-cognition-in-people-with-progressive-multiple-sclerosis-using-aerobic-exercise-and-cognitive-rehabilitation-105612https://curecurrent.com/trials/the-effect-of-extra-virgin-olive-oil-in-people-with-multiple-sclerosis-105613https://curecurrent.com/trials/role-of-individualized-versus-traditional-exercise-in-combating-fatigue-105614https://curecurrent.com/trials/can-fatigability-neuromuscular-explain-chronic-fatigue-in-people-with-multiple-sclerosis-105615https://curecurrent.com/trials/long-term-outcomes-and-durability-of-effect-following-treatment-with-cladribine-tablets-for-ms-classic-ms-105616https://curecurrent.com/trials/study-of-the-tolerability-and-pharmacokinetics-of-oral-doses-of-sar442168-with-a-food-effect-investigation-in-healthy-ad-105617https://curecurrent.com/trials/aspirin-for-exercise-in-multiple-sclerosis-aspire-105618https://curecurrent.com/trials/the-effect-of-proprioceptive-neuromuscular-facilitation-techniqueson-in-patients-with-multiple-sclerosis-105619https://curecurrent.com/trials/investigation-of-factors-affecting-functional-capasity-in-multiple-sclerosis-105620https://curecurrent.com/trials/real-world-analysis-on-lymphocyte-reconstitution-after-lymphopenia-in-participants-treated-by-tecfidera-105621https://curecurrent.com/trials/evaluation-of-clinical-morphologic-and-biochemical-markers-in-multiple-sclerosis-105622https://curecurrent.com/trials/non-invasive-spinal-cord-stimulation-for-spasticity-control-and-augmentation-of-voluntary-motor-control-in-individuals-w-105623https://curecurrent.com/trials/study-of-behavioral-modification-program-and-mirabegron-to-improve-urinary-urgency-in-multiple-sclerosis-105624https://curecurrent.com/trials/cognitive-function-in-multiple-sclerosis-105625https://curecurrent.com/trials/allogeneic-stem-cell-transplantation-for-the-treatment-of-multiple-sclerosis-105626https://curecurrent.com/trials/a-safety-and-efficacy-study-of-fcr001-in-adults-with-rapidly-progressive-diffuse-cutaneous-systemic-sclerosis-105627https://curecurrent.com/trials/use-of-a-tonometer-to-identify-epileptogenic-lesions-during-pediatric-epilepsy-surgery-105628https://curecurrent.com/trials/telemonitoring-and-connected-care-applied-to-multiple-sclerose-105629https://curecurrent.com/trials/validation-of-ella-platform-for-serum-nfl-and-gfap-measures-in-multiple-sclerosis-patients-105630https://curecurrent.com/trials/exercise-and-pregnancy-in-people-with-multiple-sclerosis-105631https://curecurrent.com/trials/brain-targets-in-patients-with-bladder-emptying-difficulties-105632https://curecurrent.com/trials/a-run-in-study-on-the-safety-and-tolerability-of-a-fasting-mimicking-diet-in-relapsing-remitting-multiple-sclerosis-105633https://curecurrent.com/trials/pilot-study-on-eeg-and-behavioral-effects-of-two-different-treatments-on-sexual-life-105634https://curecurrent.com/trials/investigation-of-subclinical-markers-of-multiple-sclerosis-105635https://curecurrent.com/trials/effect-of-computerized-cognitive-training-in-persons-with-ms-105636https://curecurrent.com/trials/aerobic-training-effects-on-motor-and-cognitive-performances-in-ms-an-exploratory-study-with-structural-and-functional-m-105637https://curecurrent.com/trials/preventing-the-progression-of-multiple-sclerosis-early-rehabilitative-treatment-and-multimodal-assessment-part-b-105638https://curecurrent.com/trials/the-relationship-of-neuropathic-pain-with-incontinence-disability-and-life-quality-in-multiple-sclerosis-patients-105639https://curecurrent.com/trials/plantar-sensitivity-training-and-aerobic-exercise-training-in-patients-with-multiple-sclerosis-plastacet-study-105640https://curecurrent.com/trials/effectiveness-and-safety-of-generic-delayed-release-dimethyl-fumarate-sclera-or-marovarex-hikma-in-routine-medical-pract-105641https://curecurrent.com/trials/effect-of-aerobic-training-vs-balance-training-on-fatigue-symptom-in-multiple-sclerosis-patient-fati-gate-105642https://curecurrent.com/trials/impact-program-for-multiple-sclerosis-105643https://curecurrent.com/trials/evaluation-of-quality-of-life-qol-in-subjects-with-highly-active-relapsing-multiple-sclerosis-ms-clarify-ms-105644https://curecurrent.com/trials/observational-trial-evaluating-elevated-factor-viii-related-labs-as-a-biomarker-for-incomplete-relapse-recovery-105645https://curecurrent.com/trials/isoelectric-focusing-of-tears-in-children-with-radiologically-isolated-or-clinically-isolated-syndrome-105646https://curecurrent.com/trials/development-and-evaluation-of-a-web-based-programme-on-relapse-management-for-people-with-multiple-sclerosis-105647https://curecurrent.com/trials/interactive-web-platform-for-empowerment-in-early-multiple-sclerosis-105648https://curecurrent.com/trials/the-effect-of-an-interactive-web-based-program-in-the-management-of-multiple-sclerosis-105649https://curecurrent.com/trials/remyelination-in-multiple-sclerosis-a-pet-mr-longitudinal-study-investigating-individual-profiles-of-myelin-repair-and-t-105650https://curecurrent.com/trials/immersive-virtual-reality-for-upper-limb-rehabilitation-in-multiple-sclerosis-105651https://curecurrent.com/trials/dose-ranging-efficacy-and-safety-study-of-topical-rapamycin-cream-for-facial-angiofibroma-associated-with-tuberous-scler-105652https://curecurrent.com/trials/outpatient-hematopoietic-grafting-in-multiple-sclerosis-employing-autologous-peripheral-blood-stem-cells-105653https://curecurrent.com/trials/wireless-implantable-tibial-nerve-stimulator-system-for-the-treatment-of-refractory-lower-urinary-tract-symptoms-in-pati-105654https://curecurrent.com/trials/effect-of-ocrelizumab-on-brain-innate-immune-microglial-cells-activation-in-ms-using-pet-mri-with-18f-dpa714-105655https://curecurrent.com/trials/digital-cognitive-behavioral-therapy-for-insomnia-for-patients-with-multiple-sclerosis-105656https://curecurrent.com/trials/physical-and-cognitive-performance-during-the-two-first-years-of-lemtrada-treatment-105657https://curecurrent.com/trials/the-relationships-between-personal-identity-autobiographical-memory-and-future-thinking-in-people-with-multiple-sclerosi-105658https://curecurrent.com/trials/influence-of-exercise-on-the-mobility-and-balance-of-individuals-with-multiple-sclerosis-105659https://curecurrent.com/trials/pediatric-sonics-pediatric-study-of-neuropsychology-and-imaging-in-cns-demyelinating-syndromes-105660https://curecurrent.com/trials/outwalk-ms-benefits-of-outdoor-walking-in-multiple-sclerosis-105661https://curecurrent.com/trials/the-effect-of-exercise-on-strength-and-mobility-and-corresponding-cns-plasticity-in-multiple-sclerosis-patients-105662https://curecurrent.com/trials/fatigue-and-sleep-quality-in-multiple-sclerosis-patients-105663https://curecurrent.com/trials/plegridy-satisfaction-study-in-participants-105664https://curecurrent.com/trials/swiss-study-of-the-impact-of-mayzent-on-spms-patients-in-a-long-term-non-interventional-study-105665https://curecurrent.com/trials/an-observational-study-on-teriflunomide-exposed-pregnancies-105666https://curecurrent.com/trials/efficacy-and-safety-of-bg00012-in-ms-105667https://curecurrent.com/trials/sleep-disorders-and-quality-of-life-in-patients-with-multiple-sclerosis-105668https://curecurrent.com/trials/the-effects-of-ethyl-alpha-guanido-methyl-ethanoate-on-skin-reactions-from-glatiramer-acetate-injections-105669https://curecurrent.com/trials/current-exercise-approaches-in-patients-with-multiple-sclerosis-105670https://curecurrent.com/trials/evaluation-of-natalizumab-for-the-relief-of-ms-associated-fatigue-105671https://curecurrent.com/trials/the-effect-of-sexual-counseling-with-the-plissit-model-on-sexual-function-and-sexual-quality-of-life-in-women-with-multi-105672https://curecurrent.com/trials/effect-of-life-kinetik-training-on-lower-limb-coordination-in-ataxic-patients-105673https://curecurrent.com/trials/physical-activity-in-persons-newly-diagnosed-with-multiple-sclerosis-105674https://curecurrent.com/trials/discontinuation-of-disease-modifying-therapies-dmts-in-multiple-sclerosis-ms-105675https://curecurrent.com/trials/combined-effect-of-transcranial-direct-current-stimulation-tdcs-and-physical-activity-on-gait-and-functional-mobility-in-105676https://curecurrent.com/trials/examining-the-impact-of-an-online-non-restrictive-diet-among-persons-with-multiple-sclerosis-105677https://curecurrent.com/trials/targeting-the-gut-dysbiosis-to-treat-inflammation-driven-synaptopathy-in-ms-105678https://curecurrent.com/trials/movement-disorders-in-multiple-sclerosis-patients-105679https://curecurrent.com/trials/placebo-controlled-study-to-assess-the-efficacy-and-safety-of-rapamycin-in-drug-resistant-epilepsy-associated-with-tuber-105680https://curecurrent.com/trials/acute-effect-of-osteopathic-visceral-mobilization-techniques-105681https://curecurrent.com/trials/sema-4a-as-a-marker-for-inflammatory-disease-in-multiple-sclerosis-105682https://curecurrent.com/trials/pilot-study-evaluating-functional-and-wellness-outcomes-of-the-shepherd-can-do-ms-program-105683https://curecurrent.com/trials/dimethyl-fumarate-dmf-tecfidera-persistence-in-rr-ms-patients-included-in-the-french-patient-support-program-orosep-105684https://curecurrent.com/trials/cladribine-vs-placebo-for-non-active-progressive-multiple-sclerosis-clasp-ms-105685https://curecurrent.com/trials/arm-swing-during-walking-in-early-multiple-sclerosis-105686https://curecurrent.com/trials/investigation-the-effect-of-conventional-vs-individualized-tdcs-intensity-to-achieve-uniform-e-fields-105687https://curecurrent.com/trials/evaluation-of-potential-predictors-of-adherence-by-investigating-a-representative-cohort-of-multiple-sclerosis-ms-patien-105688https://curecurrent.com/trials/us-promybetaapp2-0-a-study-to-learn-more-about-the-medication-usage-and-patient-reported-outcomes-via-the-mybetaapp-in-m-105689https://curecurrent.com/trials/china-national-registry-of-neuro-inflammatory-diseases-105690https://curecurrent.com/trials/silent-progression-activity-monitoring-spam-study-105691https://curecurrent.com/trials/my-ms-toolkit-a-symptom-self-management-program-for-multiple-sclerosis-105692https://curecurrent.com/trials/trial-to-evaluate-the-effect-of-nabiximols-oromucosal-spray-on-clinical-measures-of-spasticity-in-participants-with-mult-105693https://curecurrent.com/trials/effect-of-high-intensity-interval-training-in-patients-with-multiple-sclerosis-105694https://curecurrent.com/trials/meeting-an-unmet-need-in-multiple-sclerosis-105695https://curecurrent.com/trials/efficiency-of-different-exercise-approaches-in-individuals-providing-primary-care-to-ms-105696https://curecurrent.com/trials/assessment-of-immune-response-in-multiple-sclerosis-patients-with-covid-19-vaccination-treated-with-ofatumumab-and-other-105697https://curecurrent.com/trials/effectiveness-of-powerball-system-in-people-with-multiple-sclerosis-105698https://curecurrent.com/trials/cognitive-motor-dual-task-training-in-patients-with-multiple-sclerosis-105699https://curecurrent.com/trials/multimodal-exploration-of-patients-with-multiple-sclerosis-for-an-early-detection-of-subtle-progression-105700https://curecurrent.com/trials/study-protocol-of-online-dbt-mindfulness-intervention-in-multiple-sclerosis-105701https://curecurrent.com/trials/effects-of-telerehabilitation-based-motor-imagery-training-on-pain-in-people-with-multiple-sclerosis-105702https://curecurrent.com/trials/osmotin-plant-protein-for-progressive-multiple-sclerosis-105703https://curecurrent.com/trials/the-use-of-arabic-otago-exercise-program-in-people-with-multiple-sclerosis-105704https://curecurrent.com/trials/mad-dog-cooking-class-series-effects-on-dietary-self-efficacy-eating-behaviors-and-health-outcomes-105705https://curecurrent.com/trials/tolerogenic-dendritic-cells-as-a-therapeutic-strategy-for-the-treatment-of-multiple-sclerosis-patients-tolervit-ms-105706https://curecurrent.com/trials/aromatherapy-with-lavender-essential-oil-in-patients-with-multiple-sclerosis-105707https://curecurrent.com/trials/digital-gait-analysis-in-the-home-environment-of-patients-with-multiple-sclerosis-105708https://curecurrent.com/trials/efficacy-and-safety-of-the-biosimilar-natalizumab-pb006-in-comparison-to-tysabri-105709https://curecurrent.com/trials/performance-and-long-term-safety-of-flowox2-0-in-patients-with-multiple-sclerosis-impact-on-spasticity-and-pain-105710https://curecurrent.com/trials/multiple-doses-of-at-1501-a201-in-adults-with-als-105711https://curecurrent.com/trials/a-personalised-radiosurgery-procedure-for-people-with-trigeminal-neuralgia-to-improve-pain-quality-of-life-and-reduce-co-105712https://curecurrent.com/trials/power-training-in-older-multiple-sclerosis-patients-105713https://curecurrent.com/trials/semi-inmersive-virtual-reality-on-upper-limb-in-multiple-sclerosis-105714https://curecurrent.com/trials/coping-and-adjusting-to-living-with-multiple-sclerosis-105715https://curecurrent.com/trials/the-effects-of-two-different-types-of-exercise-programs-to-increase-physical-activity-in-patients-with-ms-105716https://curecurrent.com/trials/symptom-burden-in-patients-treated-with-ocrelizumab-for-multiple-sclerosis-105717https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-dimethyl-fumarate-tecfidera-and-peginterferon-beta-1a-plegridy-for-the-trea-105718https://curecurrent.com/trials/prediction-of-non-motor-symptoms-in-fully-ambulatory-ms-patients-using-vocal-biomarkers-105719https://curecurrent.com/trials/puro-pulmonary-rehabilitation-with-o-ragt-platform-105720https://curecurrent.com/trials/closed-kinetic-chain-exercises-for-balance-and-gait-rehabilitation-for-people-with-ms-105721https://curecurrent.com/trials/study-of-gynecological-follow-up-concerning-women-with-multiple-sclerosis-105722https://curecurrent.com/trials/feasibility-of-neuromodulation-with-connectivity-guided-itbs-for-cognitive-impairment-in-ms-105723https://curecurrent.com/trials/feasibility-and-safety-of-the-360-degree-turn-test-delivered-via-telehealth-105724https://curecurrent.com/trials/mesenchymal-stem-cells-for-multiple-sclerosis-105725https://curecurrent.com/trials/study-to-evaluate-oral-biib061-added-to-interferon-beta1-ifn-1-or-glatiramer-acetate-in-relapsing-multiple-sclerosis-rms-105726https://curecurrent.com/trials/mesenchymal-stem-cells-for-progressive-multiple-sclerosis-sweden-105727https://curecurrent.com/trials/the-wearing-off-effect-of-dmt-105728https://curecurrent.com/trials/anti-inflammatory-diet-consultation-for-those-with-neuromuscular-disability-105729https://curecurrent.com/trials/the-effect-of-the-level-of-hand-fatigability-on-multiple-sclerosis-on-general-fatigue-and-functionality-105730https://curecurrent.com/trials/physical-activity-intervention-for-improving-vascular-comorbidity-risk-in-multiple-sclerosis-105731https://curecurrent.com/trials/study-of-diroximel-fumarate-in-the-real-world-setting-105732https://curecurrent.com/trials/dimethyl-fumarate-dmf-observational-study-105733https://curecurrent.com/trials/il-2-signaling-and-polarization-of-regulatory-lbs-involvement-in-multiple-sclerosis-105734https://curecurrent.com/trials/exercise-training-in-pediatric-onset-multiple-sclerosis-patients-105735https://curecurrent.com/trials/time-at-home-feasibility-study-evaluation-of-a-virtually-delivered-community-based-task-oriented-exercise-program-105736https://curecurrent.com/trials/effects-of-physical-therapy-and-dalfampridine-on-functional-mobility-in-non-ambulatory-persons-with-multiple-sclerosis-105737https://curecurrent.com/trials/lower-urinary-tract-symptoms-in-systemic-sclerosis-105738https://curecurrent.com/trials/cognitive-improvement-through-tdcs-for-patients-with-multiple-sclerosis-105739https://curecurrent.com/trials/proprioceptive-neuromuscular-facilitation-in-multiple-sclerosis-105740https://curecurrent.com/trials/capillary-dysfunction-and-cd46-immunoreceptor-cd46-type-in-ms-105741https://curecurrent.com/trials/exploring-diroximel-fumarate-real-world-experience-in-canada-and-israel-105742https://curecurrent.com/trials/sunlight-mediated-inter-organ-leukocyte-exchange-105743https://curecurrent.com/trials/improving-cognitive-aptitudes-with-tdcs-in-patients-with-multiple-sclerosis-105744https://curecurrent.com/trials/trial-of-safety-tolerability-and-efficacy-of-trametinib-snr1611-in-patients-with-amyotrophic-lateral-sclerosis-als-105745https://curecurrent.com/trials/a-study-of-sativex-for-relief-of-spasticity-in-subjects-with-multiple-sclerosis-105746https://curecurrent.com/trials/evaluate-the-maintenance-of-effect-after-long-term-treatment-with-sativex-in-subjects-with-symptoms-of-spasticity-due-to-105747https://curecurrent.com/trials/endeavor-in-pediatric-ms-105748https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-sativex-for-the-relief-of-symptoms-of-spasticity-in-subjects-from-phase-b-wit-105749https://curecurrent.com/trials/a-study-of-the-long-term-safety-of-sativex-use-105750https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-sativex-in-relieving-symptoms-of-spasticity-due-to-multiple-sclerosis-105751https://curecurrent.com/trials/the-effect-of-telerehabilitation-on-balance-in-people-with-multiple-sclerosis-105752https://curecurrent.com/trials/a-trial-of-bile-acid-supplementation-in-patients-with-multiple-sclerosis-105753https://curecurrent.com/trials/a-parallel-group-study-to-compare-sativex-with-placebo-in-the-treatment-of-detrusor-overactivity-in-patients-with-multip-105754https://curecurrent.com/trials/the-effect-of-hope-placement-program-on-d-agnosed-w-th-ms-105755https://curecurrent.com/trials/aggressive-onset-multiple-sclerosis-a-practical-definition-and-study-of-its-clinical-course-105756https://curecurrent.com/trials/non-inferiority-study-of-rituximab-compared-to-ocrelizumab-in-relapsing-ms-105757https://curecurrent.com/trials/augmenting-cerebral-blood-flow-to-treat-established-multiple-sclerosis-105758https://curecurrent.com/trials/a-trial-of-neuroprotection-with-acth-in-acute-optic-neuritis-105759https://curecurrent.com/trials/personalized-extended-interval-dosing-of-natalizumab-in-relapsing-remitting-multiple-sclerosis-105760https://curecurrent.com/trials/effects-of-a-ct-100-dinamo-component-on-cognitive-functioning-and-mood-symptoms-105761https://curecurrent.com/trials/mayzent-siponimod-onboarding-of-secondary-progressive-multiple-sclerosis-spms-patients-with-msgo-105762https://curecurrent.com/trials/a-phase-2-study-of-orelabrutinib-in-patients-with-relapsing-remitting-multiple-sclerosis-105763https://curecurrent.com/trials/feasibility-of-a-high-intensity-interval-training-program-in-persons-with-multiple-sclerosis-who-have-walking-disability-105764https://curecurrent.com/trials/to-evaluate-the-safety-and-efficacy-of-teriflunomide-in-patients-with-relapsing-forms-of-multiple-sclerosis-105765https://curecurrent.com/trials/ms-paths-covid-19-questionnaire-data-linkage-sub-study-105766https://curecurrent.com/trials/study-to-investigate-pregnancy-outcomes-in-female-participants-exposed-to-subcutaneous-sc-peginterferon-beta-1a-and-intr-105767https://curecurrent.com/trials/validation-of-digicog-and-konectom-tools-to-support-digitalized-clinical-assessment-in-multiple-sclerosis-105768https://curecurrent.com/trials/trabecular-bone-score-in-multiple-sclerosis-105769https://curecurrent.com/trials/multiple-sclerosis-the-role-of-mitochondrial-dysfunction-in-ir-resistance-105770https://curecurrent.com/trials/clinical-decision-support-system-cadims-for-ms-diagnostic-105771https://curecurrent.com/trials/sensing-physical-activity-to-evaluate-and-monitor-a-routine-aftercare-program-sense-m-105772https://curecurrent.com/trials/muscle-vibration-and-fatigue-in-patients-with-ms-105773https://curecurrent.com/trials/regional-non-comparative-prospective-study-of-the-impact-of-gamma-knife-radiosurgery-on-tremor-in-multiple-sclerosis-105774https://curecurrent.com/trials/mitoq-for-fatigue-in-multiple-sclerosis-105775https://curecurrent.com/trials/adjunctive-ganaxolone-treatment-part-a-in-tsc-followed-by-long-term-treatment-part-b-105776https://curecurrent.com/trials/efficacy-of-covid-19-vaccination-in-patients-with-multiple-sclerosis-treated-with-immune-modulating-medication-105777https://curecurrent.com/trials/nanocrystalline-gold-to-treat-remyelination-failure-in-chronic-optic-neuropathy-in-multiple-sclerosis-105778https://curecurrent.com/trials/single-multiple-ascending-dose-study-of-sar443820-in-healthy-adult-participants-105779https://curecurrent.com/trials/lymphangioleiomyomatosis-a-study-on-cathepsin-k-105780https://curecurrent.com/trials/national-multicenter-controlled-single-blind-study-with-two-parallel-groups-evaluating-the-safety-and-efficacy-of-sequen-105781https://curecurrent.com/trials/defining-an-immunological-signature-related-to-lesion-location-in-multiple-sclerosis-105782https://curecurrent.com/trials/behavior-and-activity-monitoring-in-ms-105783https://curecurrent.com/trials/minocycline-in-ms-confirmation-of-benefit-105784https://curecurrent.com/trials/a-randomized-controlled-trial-of-a-multicomponent-walking-aid-program-for-people-with-ms-105785https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-long-term-treatment-with-teriflunomide-14-mg-once-daily-in-patients-with-a-first-clini-105786https://curecurrent.com/trials/determination-of-compliance-to-mediterranean-diet-impacts-on-walking-and-quality-of-life-in-multiple-sclerosis-105787https://curecurrent.com/trials/drug-repurposing-using-metformin-for-improving-the-therapeutic-outcome-in-multiple-sclerosis-patients-105788https://curecurrent.com/trials/randomized-double-blinded-study-of-treatment-teriflunomide-in-radiologically-isolated-syndrome-105789https://curecurrent.com/trials/evaluation-of-the-onset-of-action-in-highly-active-ms-magnify-105790https://curecurrent.com/trials/pilot-study-of-the-safety-and-tolerability-of-l-dlpfc-itbs-rtms-for-mdd-in-ms-105791https://curecurrent.com/trials/intranasal-insulin-for-improving-cognitive-function-in-multiple-sclerosis-105792https://curecurrent.com/trials/assessing-the-feasibility-of-the-mspt-device-in-routine-clinical-practice-in-the-swiss-healthcare-system-105793https://curecurrent.com/trials/diaphragm-pacing-system-dps-in-participants-with-amyotrophic-lateral-sclerosis-als-105794https://curecurrent.com/trials/effect-of-bio-electromagnetic-energy-regulation-therapy-on-erectile-dysfunction-in-patients-with-multiple-sclerosis-105795https://curecurrent.com/trials/czech-pharmaco-epidemiological-study-on-disease-modifying-drugs-105796https://curecurrent.com/trials/addition-of-belimumab-to-b-cell-depletion-in-relapsing-remitting-multiple-sclerosis-105797https://curecurrent.com/trials/physical-activity-sedentary-behaviour-and-cardiometabolic-health-in-multiple-sclerosis-105798https://curecurrent.com/trials/pain-in-neurorehabilitation-through-wearable-devices-an-exploratory-study-105799https://curecurrent.com/trials/ms-paths-normative-sub-study-105800https://curecurrent.com/trials/a-study-of-lp-168-in-healthy-volunteers-105801https://curecurrent.com/trials/performance-and-long-term-safety-of-flowox2-0-multiple-sclerosis-spasticity-and-pain-105802https://curecurrent.com/trials/the-reliability-and-validity-of-the-l-test-in-patients-with-multiple-sclerosis-105803https://curecurrent.com/trials/study-of-efficacy-and-safety-of-drugs-bcd-033-and-rebif-for-treatment-of-patients-with-multiple-sclerosis-105804https://curecurrent.com/trials/dalfampridine-in-egyptian-patients-with-multiple-sclerosis-105805https://curecurrent.com/trials/assessment-of-language-disorders-in-multiple-sclerosis-patients-105806https://curecurrent.com/trials/ptns-on-urinary-and-global-quality-of-life-in-ms-patients-105807https://curecurrent.com/trials/biomarkers-for-tuberous-sclerosis-complex-biotusccom-105808https://curecurrent.com/trials/the-effect-of-augmented-reality-based-telerehabilitation-application-on-neuromuscular-and-sensorimotor-parameters-in-mul-105809https://curecurrent.com/trials/rhythmic-auditory-stimulation-gait-training-105810https://curecurrent.com/trials/the-effect-of-motor-imagery-on-balance-in-persons-with-multiple-sclerosis-105811https://curecurrent.com/trials/lorraine-registry-of-multiple-sclerosis-105812https://curecurrent.com/trials/a-pilot-nutrition-program-for-spinal-cord-injury-and-ms-105813https://curecurrent.com/trials/patient-experiences-of-multiple-sclerosis-pexms-105814https://curecurrent.com/trials/evaluation-of-an-automatic-segmentation-software-pixyl-neuro-to-track-lesions-in-multiple-sclerosis-patients-via-cerebra-105815https://curecurrent.com/trials/robot-assisted-gait-training-on-mobility-in-severely-disabled-multiple-sclerosis-patients-105816https://curecurrent.com/trials/risk-factors-in-early-multiple-sclerosis-105817https://curecurrent.com/trials/assessment-of-quality-of-life-and-psychological-problems-in-patients-with-multiple-sclerosis-105818https://curecurrent.com/trials/a-study-of-lu-ag06466-for-the-treatment-of-spasticity-in-participants-with-multiple-sclerosis-105819https://curecurrent.com/trials/intervention-for-young-adults-with-multiple-sclerosis-105820https://curecurrent.com/trials/immunoregulatory-effect-of-microparticle-delivered-sting-agonist-in-the-control-of-experimental-autoimmune-encephalomyel-105821https://curecurrent.com/trials/feasibility-of-the-multiple-sclerosis-performance-test-in-participants-with-multiple-sclerosis-105822https://curecurrent.com/trials/main-study-switch-sub-study-switch-jcv-105823https://curecurrent.com/trials/multiple-sclerosis-and-respiratory-and-functional-capacity-105824https://curecurrent.com/trials/tdcs-and-glucose-uptake-in-leg-muscles-105825https://curecurrent.com/trials/a-multicenter-study-to-assess-response-to-covid-19-vaccine-in-multiple-sclerosis-participants-treated-with-ofatumumab-105826https://curecurrent.com/trials/the-effects-of-vestibular-exercise-and-cervical-stabilization-exercise-training-on-balance-and-gait-in-ms-patients-105827https://curecurrent.com/trials/expression-profile-of-erk5-and-pkm2-kinases-in-neuroinflammatory-diseases-105828https://curecurrent.com/trials/assessment-of-deep-gray-matter-anatomic-changes-in-rrms-patients-treated-with-gilenya-with-and-without-cognitive-impairm-105829https://curecurrent.com/trials/a-randomized-study-of-sativex-on-cognitive-function-and-mood-multiple-sclerosis-patients-105830https://curecurrent.com/trials/an-investigation-of-delta-9-tetrahydrocannabinol-thc-and-cannabidiol-cbd-in-multiple-sclerosis-patients-105831https://curecurrent.com/trials/an-study-to-investigate-the-efficacy-of-delta-9-tetrahydrocannabinol-thc-and-cannabidiol-cbd-in-multiple-sclerosis-105832https://curecurrent.com/trials/a-long-term-safety-extension-study-of-delta-9-tetrahydrocannabinol-thc-and-cannabidiol-cbd-in-multiple-sclerosis-105833https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-cannabis-based-medicine-in-patients-with-pain-of-neurological-origin-105834https://curecurrent.com/trials/a-study-of-sativex-in-the-treatment-of-central-neuropathic-pain-due-to-multiple-sclerosis-105835https://curecurrent.com/trials/methylprednisolone-during-the-switch-between-natalizumab-and-fingolimod-105836https://curecurrent.com/trials/covid-19-and-sars-cov-2-antibodies-in-multiple-sclerosis-patients-105837https://curecurrent.com/trials/comparative-bioavailability-of-bafiertam-monomethyl-fumarate-and-tecfidera-dimethyl-fumarate-in-healthy-subjects-105838https://curecurrent.com/trials/the-effect-of-a-gluten-free-diet-on-the-permeability-of-the-blood-brain-barrier-in-patients-with-cis-105839https://curecurrent.com/trials/cognitive-behavioral-therapy-modafinil-or-both-for-multiple-sclerosis-fatigue-105840https://curecurrent.com/trials/mechanistic-studies-of-teriflunomide-in-rrms-105841https://curecurrent.com/trials/patient-centered-outcomes-analysis-for-ms-using-a-mobile-application-105842https://curecurrent.com/trials/transcranial-direct-current-stimulation-and-walking-in-multiple-sclerosis-105843https://curecurrent.com/trials/an-extension-of-the-tg1101-rms201-trial-105844https://curecurrent.com/trials/ocrelizumab-in-breastmilk-105845https://curecurrent.com/trials/a-study-of-mitoxantrone-hydrochloride-liposome-injection-for-relapsing-multiple-sclerosis-105846https://curecurrent.com/trials/teriflunomide-concentration-in-serum-and-cerebrospinal-fluid-from-patients-with-multiple-sclerosis-105847https://curecurrent.com/trials/novel-nanosensor-array-for-detection-of-volatile-biomarkers-from-skin-in-multiple-sclerosis-105848https://curecurrent.com/trials/remote-exercise-effects-on-cognitive-processing-speed-in-multiple-sclerosis-a-pilot-trial-105849https://curecurrent.com/trials/comparison-of-two-physical-activity-interventions-in-individuals-with-multiple-sclerosis-105850https://curecurrent.com/trials/effect-of-vestibular-rehabilitation-on-trunk-kinetic-and-kinematic-parameters-in-patients-with-multiple-sclerosis-105851https://curecurrent.com/trials/transcranial-direct-current-stimulation-to-lower-neuropathic-pain-in-people-with-multiple-sclerosis-105852https://curecurrent.com/trials/lipid-mediators-in-multiple-sclerosis-105853https://curecurrent.com/trials/sensation-motion-and-quality-of-life-on-natalizumab-and-off-natalizumab-105854https://curecurrent.com/trials/covid-19-booster-vaccination-in-persons-with-multiple-sclerosis-105855https://curecurrent.com/trials/activity-and-balanced-eating-to-reduce-comorbidities-and-symptoms-of-ms-105856https://curecurrent.com/trials/under-and-over-rehabilitation-study-105857https://curecurrent.com/trials/computerized-cognitive-rehabilitation-in-ms-patients-105858https://curecurrent.com/trials/immunisation-status-and-safety-of-vaccines-in-italian-ms-patients-105859https://curecurrent.com/trials/description-of-adherence-to-the-main-preventive-health-campaigns-of-persons-with-multiple-sclerosis-105860https://curecurrent.com/trials/tenofovir-alafenamide-for-treatment-of-symptoms-and-neuroprotection-in-relapsing-remitting-multiple-sclerosis-105861https://curecurrent.com/trials/electrical-stimulations-on-pain-functional-capacity-and-quality-of-life-in-multiple-sclerosis-105862https://curecurrent.com/trials/resilience-in-young-adults-newly-diagnosed-with-multiple-sclerosis-105863https://curecurrent.com/trials/ms-and-nmosd-in-african-americans-105864https://curecurrent.com/trials/diagnosis-of-on-with-or-without-ms-or-nmosd-105865https://curecurrent.com/trials/safety-and-efficacy-study-of-doxycycline-in-combination-with-interferon-b-1a-to-treat-multiple-sclerosis-105866https://curecurrent.com/trials/characterization-of-early-patients-initiating-ofatumumab-for-treatment-of-multiple-sclerosis-105867https://curecurrent.com/trials/risk-perception-in-multiple-sclerosis-105868https://curecurrent.com/trials/acute-optic-neuritis-network-an-international-study-that-invesitages-subjects-with-a-first-ever-episode-of-acute-inflamm-105869https://curecurrent.com/trials/lesion-load-and-location-in-relation-to-cognition-fatigue-and-physical-disability-in-rrms-105870https://curecurrent.com/trials/estimating-prevalence-of-covid-19-infection-and-sars-cov-2-antibodies-in-ms-patients-105871https://curecurrent.com/trials/early-exercise-efforts-in-multiple-sclerosis-105872https://curecurrent.com/trials/fmt-for-ms-patients-105873https://curecurrent.com/trials/accurate-diagnosis-of-multiple-sclerosis-using-pet-mr-105874https://curecurrent.com/trials/time-and-motion-study-for-ocrelizumab-and-ofatumumab-administration-in-relapsing-multiple-sclerosis-105875https://curecurrent.com/trials/evaluation-of-safety-tolerability-and-preliminary-efficacy-of-ehp-101-in-relapsing-forms-of-multiple-sclerosis-105876https://curecurrent.com/trials/turkish-version-of-f-2-ms-105877https://curecurrent.com/trials/effects-of-ofatumumab-treatment-on-immune-cells-and-meningeal-lymphatic-drainage-in-patients-with-demyelinating-diseases-105878https://curecurrent.com/trials/neurogenic-lower-urinary-tract-symptoms-in-patients-with-multiple-sclerosis-105879https://curecurrent.com/trials/efficacy-and-safety-of-xacrel-ocrelizumab-in-participants-with-relapsing-remitting-multiple-sclerosis-105880https://curecurrent.com/trials/efficacy-and-safety-of-peginterferon-beta-1a-cinnagen-in-participants-with-relapsing-remitting-multiple-sclerosis-105881https://curecurrent.com/trials/natural-history-of-multiple-sclerosis-and-its-mimickers-105882https://curecurrent.com/trials/reinventing-yourself-with-multiple-sclerosis-ms-105883https://curecurrent.com/trials/analysis-of-the-distribution-of-regulatory-b-cells-in-blood-of-multiple-sclerosis-patients-105884https://curecurrent.com/trials/transient-and-immediate-motor-effects-of-exercise-in-progressive-multiple-sclerosis-105885https://curecurrent.com/trials/neurofilament-light-chain-chitinase-3-like-1-proteins-and-plasmacytoid-dendritic-cells-in-multiple-sclerosis-105886https://curecurrent.com/trials/figure-of-8-walk-test-in-multiple-sclerosis-105887https://curecurrent.com/trials/gentlecath-air-urinary-self-catheterization-pain-in-female-patients-with-neurological-vesico-sphincter-disorders-105888https://curecurrent.com/trials/effectiveness-of-telerehabilitation-interventions-in-multiple-sclerosis-105889https://curecurrent.com/trials/effect-of-arm-ergometer-exercise-training-on-upper-extremity-function-in-people-with-multiple-sclerosis-105890https://curecurrent.com/trials/high-intensity-interval-gait-training-in-multiple-sclerosis-105891https://curecurrent.com/trials/open-label-study-to-evaluate-safety-tolerability-and-pk-of-bhv-0223-in-als-105892https://curecurrent.com/trials/pet-study-to-determine-the-relationship-between-plasma-concentrations-and-muscarinic-type-1-receptor-m1achr-occupancy-of-105893https://curecurrent.com/trials/natural-history-of-optic-neuritis-105894https://curecurrent.com/trials/the-effect-of-transcranial-direct-current-stimulation-on-fatigue-among-multiple-sclerosis-patients-patients-105895https://curecurrent.com/trials/a-randomized-controlled-trial-of-cannabidiol-gwp42003-p-cbd-for-seizures-in-tuberous-sclerosis-complex-gwpcare6-105896https://curecurrent.com/trials/vitamin-d-supplementation-in-multiple-sclerosis-105897https://curecurrent.com/trials/dysport-treatment-of-urinary-incontinence-in-adults-subjects-with-neurogenic-detrusor-overactivity-ndo-due-to-spinal-cor-105898https://curecurrent.com/trials/effect-of-the-vojta-therapy-in-patients-multiple-sclerosis-105899https://curecurrent.com/trials/dysport-treatment-of-urinary-incontinence-in-adults-subjects-with-neurogenic-detrusor-overactivity-ndo-due-to-spinal-cor-105900https://curecurrent.com/trials/neurogenic-detrusor-overactivity-following-spinal-cord-injury-or-multiple-sclerosis-105901https://curecurrent.com/trials/plegridy-observational-program-105902https://curecurrent.com/trials/analysis-of-neurodegenerative-process-within-visual-ways-in-multiple-sclerosis-105903https://curecurrent.com/trials/vaginal-estriol-in-multiple-sclerosis-105904https://curecurrent.com/trials/endurance-and-walking-training-by-nordic-walking-in-multiple-sclerosis-105905https://curecurrent.com/trials/study-of-lisdexamfetamine-sulfate-to-treat-cognitive-dysfunction-in-multiple-sclerosis-105906https://curecurrent.com/trials/imaging-of-intracerebral-inflammation-in-ms-105907https://curecurrent.com/trials/manganese-enhanced-magnetic-resonance-imaging-in-healthy-volunteers-and-people-with-multiple-sclerosis-105908https://curecurrent.com/trials/cpap-to-treat-cognitive-dysfunction-in-ms-105909https://curecurrent.com/trials/who-benefits-most-from-cognitive-rehabilitation-for-multiple-sclerosis-105910https://curecurrent.com/trials/high-intensity-interval-gait-training-in-multiple-sclerosis-105911https://curecurrent.com/trials/relationship-between-oral-dmt-burden-and-adherence-in-ms-105912https://curecurrent.com/trials/effect-of-acupuncture-on-heart-rate-variability-in-multiple-sclerosis-105913https://curecurrent.com/trials/validity-and-reliability-of-turkish-version-leg-activity-measure-105914https://curecurrent.com/trials/pharmacogenetics-of-liver-toxicity-in-patients-with-multiple-sclerosis-treated-with-fingolimod-105915https://curecurrent.com/trials/tdcs-to-lower-neuropathic-pain-and-fatigue-in-people-with-multiple-sclerosis-105916https://curecurrent.com/trials/fampridine-sr-and-optic-neuritis-recovery-105917https://curecurrent.com/trials/the-effect-of-backward-walking-training-on-balance-gait-and-functional-mobility-in-patients-with-multiple-sclerosis-105918https://curecurrent.com/trials/connect-trial-of-esupport-online-health-coach-moderated-support-groups-for-multiple-sclerosis-105919https://curecurrent.com/trials/a-measurement-study-of-tis-modnv-and-accugait-force-platform-in-people-with-ms-105920https://curecurrent.com/trials/effect-of-disease-modifying-therapy-on-antibody-response-to-covid19-vaccination-in-multiple-sclerosis-105921https://curecurrent.com/trials/cellular-microrna-signatures-in-multiple-sclerosis-105922https://curecurrent.com/trials/high-intensity-resistance-training-in-people-with-multiple-sclerosis-experiencing-fatigue-105923https://curecurrent.com/trials/botulinum-toxin-in-patients-with-spastic-lower-limb-paresis-associated-with-multiple-sclerosis-105924https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-of-arbaclofen-extended-release-tablets-for-patients-with-spasticity-due-to-ms-105925https://curecurrent.com/trials/effect-of-pilates-training-in-patients-with-multiple-sclerosis-105926https://curecurrent.com/trials/clinical-factors-associated-with-position-sense-in-patients-with-multiple-sclerosis-105927https://curecurrent.com/trials/relationship-of-position-sense-with-gait-and-balance-in-patients-with-multiple-sclerosis-105928https://curecurrent.com/trials/muscle-fatigue-in-patients-with-multiple-sclerosis-105929https://curecurrent.com/trials/characterization-of-patients-with-tuberous-sclerosis-complex-lymphangioleiomyomatosis-and-angiomyolipoma-105930https://curecurrent.com/trials/profile-of-adherence-to-therapy-and-interventions-to-promote-adherence-in-ms-105931https://curecurrent.com/trials/an-assistive-powered-wheelchair-stage-2-trial-105932https://curecurrent.com/trials/covid-19-on-disease-activity-in-radiologically-isolated-syndrome-cohort-105933https://curecurrent.com/trials/effect-of-tai-chi-on-balance-mood-cognition-and-quality-of-life-in-patients-with-multiple-sclerosis-105934https://curecurrent.com/trials/a-study-of-alks-8700-in-adults-with-relapsing-remitting-multiple-sclerosis-ms-evolve-ms-1-105935https://curecurrent.com/trials/multiple-sclerosis-outcome-determination-evaluating-real-differences-after-time-105936https://curecurrent.com/trials/effect-of-home-exercise-program-on-various-parameters-in-patients-with-multiple-sclerosis-105937https://curecurrent.com/trials/investigation-of-the-effects-of-technology-supported-different-physiotherapy-approaches-on-patients-with-multiple-sclero-105938https://curecurrent.com/trials/memory-rehabilitation-strategies-in-patients-with-multiple-sclerosis-105939https://curecurrent.com/trials/allogeneic-stem-cell-transplantation-for-the-treatment-of-multiple-sclerosis-compassionate-use-105940https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-effectiveness-of-arbaclofen-extended-release-tablets-for-patients-with-ms-105941https://curecurrent.com/trials/an-open-label-extension-trial-of-cannabidiol-gwp42003-p-cbd-for-seizures-in-tuberous-sclerosis-complex-gwpcare6-105942https://curecurrent.com/trials/normobaric-hypoxic-training-and-multiple-sclerosis-105943https://curecurrent.com/trials/relaxahead-for-headache-patients-phase-i-105944https://curecurrent.com/trials/impact-of-core-performance-on-functional-parameters-in-multiple-sclerosis-105945https://curecurrent.com/trials/sensory-integration-disorders-in-patients-with-ms-including-disease-advancement-and-relapses-in-the-last-year-105946https://curecurrent.com/trials/a-long-term-extension-of-study-gnc-401-105947https://curecurrent.com/trials/polish-translation-and-validation-of-nbss-qualiveen-and-sf-qualiveen-105948https://curecurrent.com/trials/delayed-diagnosis-of-multiple-sclerosis-treatment-initiation-and-non-adherence-in-upper-egypt-105949https://curecurrent.com/trials/qualitative-study-patient-physician-experiences-botox-covid-19-105950https://curecurrent.com/trials/rhythmic-auditory-stimulation-and-walking-performance-in-multiple-sclerosis-ms-patients-105951https://curecurrent.com/trials/pilot-study-of-powered-exoskeleton-use-for-gait-rehabilitation-in-individuals-with-multiple-sclerosis-105952https://curecurrent.com/trials/polysomnographic-titration-of-non-invasive-ventilation-in-motor-neurone-disease-105953https://curecurrent.com/trials/biogen-multiple-sclerosis-pregnancy-exposure-registry-105954https://curecurrent.com/trials/effects-of-a-home-based-walking-program-using-rhythmic-auditory-stimulation-in-patients-with-multiple-sclerosis-105955https://curecurrent.com/trials/deficient-t-regulatory-cell-treg-function-in-patients-with-relapsing-remitting-multiple-sclerosis-105956https://curecurrent.com/trials/designing-virtual-reality-based-software-for-people-with-multiple-sclerosis-105957https://curecurrent.com/trials/the-influence-of-hiit-versus-mct-on-cardiorespiratory-fitness-in-ppms-105958https://curecurrent.com/trials/demyelinating-diseases-of-the-central-nervous-system-registry-for-patients-with-traditional-chinese-medicine-date-tcm-105959https://curecurrent.com/trials/training-and-energy-management-education-to-improve-quality-of-life-in-persons-with-multiple-sclerosis-105960https://curecurrent.com/trials/accelerated-brain-volume-loss-in-people-with-multiple-sclerosis-105961https://curecurrent.com/trials/the-effect-of-covid-19-on-the-disease-course-of-multiple-sclerosis-belgian-lessons-learned-from-rocky-i-to-rocky-iv-105962https://curecurrent.com/trials/il-11-in-the-development-of-multiple-sclerosis-105963https://curecurrent.com/trials/investigating-the-effect-of-ocrelizumab-in-african-americans-and-caucasians-with-relapsing-multiple-sclerosis-105964https://curecurrent.com/trials/aerobic-exercise-in-persons-with-multiple-sclerosis-with-restless-legs-syndrome-105965https://curecurrent.com/trials/quantifying-gait-alteration-in-multiple-sclerosis-using-a-wearable-device-105966https://curecurrent.com/trials/a-study-of-orally-administered-bgc20-0134-structured-lipid-in-patients-with-relapsing-remitting-multiple-sclerosis-rrms-105967https://curecurrent.com/trials/lifestyle-intervention-for-patients-with-multiple-sclerosis-105968https://curecurrent.com/trials/telerehabilitation-based-upper-extremity-training-in-people-with-multiple-sclerosis-105969https://curecurrent.com/trials/metacognition-assessment-in-patient-with-multiple-sclerosis-105970https://curecurrent.com/trials/exergaming-in-persons-with-multiple-sclerosis-with-restless-legs-syndrome-105971https://curecurrent.com/trials/video-game-based-physical-activity-training-in-people-with-multiple-sclerosis-during-relapse-treatment-105972https://curecurrent.com/trials/validity-and-reliability-of-the-dual-task-questionnaire-105973https://curecurrent.com/trials/the-effect-of-telerehabilitation-based-pilates-training-in-multiple-sclerosis-patients-105974https://curecurrent.com/trials/efficacy-of-tdcs-on-pain-in-multiple-sclerosis-105975https://curecurrent.com/trials/ris-international-cohort-105976https://curecurrent.com/trials/algorithmic-based-evaluation-and-treatment-approach-for-robotic-gait-training-105977https://curecurrent.com/trials/muscle-nordic-walking-in-multiple-sclerosis-105978https://curecurrent.com/trials/clinical-correlates-of-psychiatric-comorbidities-in-patients-with-multiple-sclerosis-105979https://curecurrent.com/trials/impact-of-physical-activity-on-cognitive-outcomes-in-youth-with-pediatric-onset-multiple-sclerosis-poms-105980https://curecurrent.com/trials/hydroxychloroquine-and-indapamide-in-spms-105981https://curecurrent.com/trials/utilization-of-the-ketogenic-diet-in-patient-with-relapsing-remitting-ms-105982https://curecurrent.com/trials/multiple-sclerosis-intimacy-and-sexuality-questionnaire-105983https://curecurrent.com/trials/intermittent-vs-continuous-walking-in-people-with-multiple-sclerosis-105984https://curecurrent.com/trials/a-long-term-follow-up-study-of-multiple-sclerosis-patients-who-participated-in-genzyme-sponsored-studies-of-gz402668-105985https://curecurrent.com/trials/microbiome-benchmarking-to-identify-perturbations-in-multiple-sclerosis-ii-105986https://curecurrent.com/trials/assessment-of-tecfidera-in-radiologically-isolated-syndrome-ris-105987https://curecurrent.com/trials/a-study-for-tecfidera-dimethyl-fumarate-capsules-in-korean-participants-with-relapsing-remitting-multiple-sclerosis-105988https://curecurrent.com/trials/isleepms-an-internet-delivered-intervention-for-sleep-disturbance-in-multiple-sclerosis-105989https://curecurrent.com/trials/validation-of-a-shared-decision-making-tool-for-multiple-sclerosis-105990https://curecurrent.com/trials/efficacy-and-safety-of-ofatumumab-compared-to-placebo-in-patients-with-relapsing-multiple-sclerosis-followed-by-extended-105991https://curecurrent.com/trials/correlation-between-relapses-in-multiple-sclerosis-ms-and-vitamin-d-intake-105992https://curecurrent.com/trials/exercise-on-contactin-1-and-contactin-2-level-in-persons-with-multiple-sclerosis-105993https://curecurrent.com/trials/efficacy-and-safety-of-biib033-opicinumab-as-an-add-on-therapy-to-disease-modifying-therapies-dmts-in-relapsing-multiple-105994https://curecurrent.com/trials/dry-needling-for-treating-spasticity-in-multiple-sclerosis-105995https://curecurrent.com/trials/to-assess-effects-of-arbaclofen-er-tablets-compared-with-placebo-on-sperm-parameters-in-male-subjects-with-ms-105996https://curecurrent.com/trials/csf-free-kappa-light-chain-for-the-diagnosis-of-demyelinating-disorders-105997https://curecurrent.com/trials/a-single-ascending-dose-study-of-gz402668-in-patients-with-progressive-multiple-sclerosis-105998https://curecurrent.com/trials/rapamycin-for-kidney-angiomyolipomas-105999https://curecurrent.com/trials/one-year-open-label-dose-escalation-long-term-safety-study-in-multiple-sclerosis-ms-subjects-with-spasticity-106000https://curecurrent.com/trials/single-ascending-dose-study-of-sar443820-in-healthy-adult-chinese-and-japanese-female-and-male-participants-106001https://curecurrent.com/trials/efficacy-study-of-arbaclofen-to-treat-spasticity-in-multiple-sclerosis-106002https://curecurrent.com/trials/investigating-the-effects-of-hydroxyvitamin-d3-on-multiple-sclerosis-106003https://curecurrent.com/trials/disability-mri-lesions-and-thickness-of-retinal-fibers-evaluation-15-years-after-a-first-episode-of-demyelination-106004https://curecurrent.com/trials/kinesiotape-on-balance-in-with-multiple-sclerosis-106005